thrombophilia: A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2824 |
4. Check minimum number of eventsNone |
2824 |
5. Include endpoints |
2874 |
6. Filter based on genotype QC (FinnGen only) |
2874 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D65-D69
- Name in latin
- Aliae defectus coagulationis
Similar endpoints
↥List of similar endpoints to
Other coagulation defects
based on the number of shared cases.
Similar with more cases:
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 20109 | 12309 | 7658 |
| Only index persons | 17670 | 11271 | 6399 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.30 | 0.35 | 0.21 |
| Only index persons | 0.35 | 0.41 | 0.24 |
| Median age at first event (years) | |||
| Whole population | 47.12 | 40.21 | 58.04 |
| Only index persons | 45.48 | 39.12 | 56.67 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2874 | 1913 | 961 |
| Unadjusted period prevalence (%) | 0.58 | 0.65 | 0.42 |
| Median age at first event (years) | 48.05 | 41.44 | 61.22 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2536
- Matched controls
- 25359
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.0
ICD-10 Finland
Von Willebrand disease
2415.4
323.0
429
*
D68.9
ICD-10 Finland
Coagulation defect, unspecified
1209.0
323.0
407
*
B01AA03
ATC
warfarin; systemic
7.9
323.0
1134
2360
B01AB05
ATC
enoxaparin; parenteral
5.6
323.0
1380
4463
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
1355.3
323.0
351
*
D68.8
ICD-10 Finland
Other specified coagulation defects
2271.6
323.0
1319
12
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
851.0
312.4
301
*
B01AB04
ATC
dalteparin; parenteral
9.4
173.1
381
469
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
49.4
151.3
184
40
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
9.8
144.6
308
353
126
Kela drug reimbursment
Chronic coagulation defects
+∞
137.8
131
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
7.5
131.2
332
501
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.5
120.3
486
1281
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
11.3
120.3
236
229
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
13.8
107.6
191
149
B02AA02
ATC
tranexamic acid; systemic
3.0
85.5
591
2339
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
17.5
76.3
122
73
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
76.2
1127
6684
Z2221
NOMESCO Finland
Medical doctor
2.3
75.9
915
4922
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
73.4
528
2119
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
69.1
524
2166
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
10.9
68.6
135
130
N02AX02
ATC
tramadol; systemic, rectal
2.1
68.0
1121
6867
ZXE00
NOMESCO Finland
One hour or less
2.1
66.7
1156
7217
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
76.3
65.4
74
10
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
65.0
1015
6039
R4110
NOMESCO Finland
Physiotherapy
2.2
59.7
751
4020
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
58.6
434
1749
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
58.6
276
805
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.0
58.0
369
1349
K94
ICPC
Phlebitis/thrombophlebitis
10.2
57.6
117
120
R06.0
ICD-10 Finland
Dyspnoea
2.2
56.8
687
3596
B01AB10
ATC
tinzaparin; parenteral
3.8
56.6
259
736
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
56.4
1049
6594
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
55.9
602
2976
Z3231
NOMESCO Finland
Registered nurse
2.1
55.3
777
4340
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
79.5
55.2
62
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
53.5
755
4216
M79.6
ICD-10 Finland
Pain in limb
2.0
52.7
960
5939
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
8.6
51.9
116
141
N02BE01
ATC
paracetamol; systemic, rectal
2.2
51.3
2160
18225
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
49.4
734
4160
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.3
48.9
190
464
ZXD05
NOMESCO Finland
Urgent procedure
2.0
48.5
902
5578
C03CA01
ATC
furosemide; systemic
2.1
48.5
662
3616
Z3226
NOMESCO Finland
Physiotherapist
2.2
46.9
540
2724
AA1AD
NOMESCO Finland
CT of head and brain
2.2
46.8
600
3180
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
466.0
46.4
46
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
43.5
768
4615
H02AB06
ATC
prednisolone; systemic
1.8
43.1
1168
8140
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
42.9
516
2645
K78
ICPC
Atrial fibrillation/flutter
3.4
42.4
225
716
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
42.1
1170
8200
ZX120
NOMESCO Finland
Intravenous
2.8
40.9
283
1079
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
4.4
40.4
152
359
C07AB07
ATC
bisoprolol; oral
1.8
40.4
1047
7143
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
40.0
966
6431
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
7.1
39.3
99
145
WX892
NOMESCO Finland
Monitored bed care
3.1
38.9
234
814
R04.0
ICD-10 Finland
Epistaxis
3.2
38.6
216
713
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
38.5
632
3665
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
38.2
215
713
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.6
38.1
182
533
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
37.6
384
1812
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
37.5
572
3220
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
37.3
371
1729
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
12.5
37.0
67
55
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
7.7
35.6
84
112
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
35.5
34
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
35.2
417
2104
J01DB01
ATC
cefalexin; oral
1.9
35.1
2051
17603
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.3
34.8
185
589
K99
ICPC
Cardiovascular disease other
4.9
34.5
116
244
2864A
ICD-9 Finland
Coagulation defects, von Willebrand's disease
+∞
34.4
33
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
33.8
915
6229
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
33.6
199
684
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
33.5
272
1134
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
8.5
33.5
74
89
R60.0
ICD-10 Finland
Localized oedema
2.5
33.3
286
1232
A02BC02
ATC
pantoprazole; systemic
1.7
32.7
1511
11930
I87.0
ICD-10 Finland
Postthrombotic syndrome
37.9
32.5
41
11
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
32.2
265
1115
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
6.9
32.1
82
123
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
32.0
352
1713
Z2446
NOMESCO Finland
Social worker
2.8
31.8
213
793
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.6
31.6
249
1020
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.5
31.6
270
1159
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
11.2
31.0
59
54
WX002
NOMESCO Finland
Sedation and analgesia
1.9
30.2
477
2693
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.5
29.6
145
433
H02AB07
ATC
prednisone; oral
2.1
28.9
376
1962
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
13.0
28.9
51
40
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
28.7
180
641
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
28.2
27
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
28.0
295
1400
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
27.9
330
1653
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
27.7
799
5463
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
27.7
174
621
R51.80
ICD-10 Finland
Headache
2.0
27.6
411
2261
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
27.5
609
3846
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
27.2
587
3678
Z71.8
ICD-10 Finland
Other specified counselling
1.7
27.0
627
4013
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
20.3
26.9
40
20
N03AX16
ATC
pregabalin; oral
1.8
26.9
555
3422
B01AX05
ATC
fondaparinux; parenteral
10.8
26.5
51
48
J01MA02
ATC
ciprofloxacin; systemic
1.6
26.5
887
6299
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
26.3
219
922
K93
ICPC
Pulmonary embolism
8.9
25.7
55
63
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
25.5
450
2628
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
25.2
233
1038
28630
ICD-8 Finland
Coagulation defects, Vascular haemophilia
+∞
25.0
24
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.0
24.9
347
1853
UJF32
NOMESCO Finland
Coloscopy
1.7
24.8
572
3642
L04AX01
ATC
azathioprine; systemic
3.1
24.7
140
466
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
24.5
518
3208
R4120
NOMESCO Finland
Occupational therapy
2.6
24.2
182
725
R50.9
ICD-10 Finland
Fever, unspecified
2.0
23.9
349
1898
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
23.8
433
2551
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
23.8
649
4332
L17
ICPC
Foot/toe symptom/complaint
1.7
23.5
582
3776
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
22.9
516
3250
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
22.8
271
1355
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
22.7
416
2452
A46
ICD-10 Finland
Erysipelas
2.0
22.4
301
1585
I26
ICD-10 Finland
Pulmonary embolism
8.4
22.4
49
59
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
6.0
22.2
62
106
J01MA12
ATC
levofloxacin; systemic
1.8
22.1
409
2414
ZXA00
NOMESCO Finland
Right side
1.7
22.1
589
3891
XF404
NOMESCO Finland
Ambulatory ECG
2.2
21.7
227
1070
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
21.7
435
2635
R03AC02
ATC
salbutamol; inhalant
1.5
21.5
1260
10059
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
21.5
128
440
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.9
21.0
59
102
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
20.9
126
438
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
20.7
264
1359
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
30.3
20.6
27
9
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
20.3
259
1333
J01FF01
ATC
clindamycin; systemic
1.6
20.1
631
4339
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
20.1
1215
9710
O22.3
ICD-10 Finland
Deep phlebothrombosis in pregnancy
17.4
20.0
31
18
A02BC01
ATC
omeprazole; systemic
1.6
20.0
625
4296
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
19.7
552
3679
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
6.9
19.7
49
72
D69.1
ICD-10 Finland
Qualitative platelet defects
201.5
19.6
20
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
19.5
150
607
J01DA01
ATC
[U] cefalexin; systemic
1.5
19.4
1479
12366
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
19.2
717
5138
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
9.9
19.1
38
39
3AC01
NOMESCO Finland
NA
6.1
19.1
52
87
D69.0
ICD-10 Finland
Allergic purpura
55.4
18.9
22
*
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.7
18.9
84
234
L04AA06
ATC
mycophenolic acid; systemic
4.6
18.8
66
148
WX402
NOMESCO Finland
General anaesthesia
1.7
18.7
391
2392
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.9
18.6
117
419
K92.1
ICD-10 Finland
Melaena
2.7
18.6
127
480
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.0
18.5
241
1249
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.9
18.4
60
124
A02BC05
ATC
esomeprazole; systemic
1.5
18.3
888
6731
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
18.2
298
1683
P01BA02
ATC
hydroxychloroquine; oral
2.1
18.1
207
1018
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
18.0
726
5276
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
18.0
697
5022
ZXA10
NOMESCO Finland
Bilateral
1.7
17.9
407
2554
Z01.7
ICD-10 Finland
Laboratory examination
1.9
17.8
268
1467
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
17.8
183
857
B01AF01
ATC
rivaroxaban; oral
2.0
17.8
242
1276
ZXA05
NOMESCO Finland
Left side
1.6
17.7
536
3633
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
22.9
17.7
25
11
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
17.7
112
403
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
17.7
225
1155
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
8.6
17.7
38
45
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
17.6
401
2514
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
17.5
182
856
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
17.5
211
1057
D68
ICD-10 Finland
Other coagulation defects
181.2
17.5
18
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
17.4
404
2547
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
21.0
17.3
25
12
I50.0
ICD-10 Finland
Congestive heart failure
2.4
17.2
150
648
R06AE07
ATC
cetirizine; oral
1.4
16.9
1031
8149
R42
ICD-10 Finland
Dizziness and giddiness
1.6
16.9
465
3074
M25.5
ICD-10 Finland
Pain in joint
1.5
16.9
644
4613
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
16.9
177
836
N02AA05
ATC
oxycodone; systemic
1.8
16.8
292
1681
R03BA02
ATC
budesonide; inhalant
1.7
16.8
413
2645
JN4BD
NOMESCO Finland
Extensive body CT
2.0
16.7
226
1187
28698
ICD-8 Finland
Coagulation defects, Other
+∞
16.7
16
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
16.7
169
787
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.9
16.6
254
1399
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
16.5
397
2528
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.9
16.4
53
109
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
16.4
90
296
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
16.3
160
732
45100
ICD-8 Finland
Phlebitis and thrombophlebitis, Of lower extremities
8.1
16.3
36
45
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.6
16.1
72
202
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
16.1
385
2447
B01AF02
ATC
apixaban; oral
2.1
16.0
185
914
L28
ICPC
Limited function/disability (L)
1.7
16.0
324
1961
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
15.9
1823
20075
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
15.9
147
653
E0000UV
ATC
NA
1.4
15.9
901
7001
I80
ICD-10 Finland
Phlebitis and thrombophlebitis
5.7
15.9
45
80
TFP20
NOMESCO Finland
Cardiodefibrillation
2.3
15.8
152
688
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
15.8
93
321
SPAT1229
SPAT
Assessment of need for aid
2.2
15.8
167
793
J01MA14
ATC
moxifloxacin; systemic
2.0
15.7
206
1068
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.4
15.6
76
229
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
15.5
1078
8696
Z31.5
ICD-10 Finland
Genetic counselling
2.3
15.4
147
663
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
15.4
169
815
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
15.3
361
2279
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
15.3
215
1145
R55
ICD-10 Finland
Syncope and collapse
1.9
15.3
231
1267
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
15.1
242
1352
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
15.0
169
826
O36.4
ICD-10 Finland
Maternal care for intrauterine death
9.0
14.9
31
35
WX110
NOMESCO Finland
Local anesthesy
1.4
14.9
1624
14155
TK800
NOMESCO Finland
Hemodialysis
4.0
14.9
59
150
K22
ICPC
Risk factor cardiovascular disease
2.6
14.8
112
450
315
Kela drug reimbursment
Clopidogrel
5.9
14.8
41
71
J01FA06
ATC
roxithromycin; oral
1.4
14.8
909
7142
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.9
14.7
59
152
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
14.6
125
534
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
80.6
14.6
16
*
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
8.5
14.5
31
37
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
14.4
150
707
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.9
14.4
59
155
W19
ICD-10 Finland
Unspecified fall
1.9
14.4
206
1108
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
14.3
168
833
C01CA24
ATC
epinephrine; parenteral
2.1
14.3
161
786
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.7
14.3
61
166
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
14.3
87
306
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
14.3
156
750
M04AA01
ATC
allopurinol; systemic
1.8
14.2
235
1327
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
14.2
249
1433
Z2445
NOMESCO Finland
Psychologist
2.4
14.2
117
492
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
14.2
261
1527
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
14.2
75
241
J01FA10
ATC
azithromycin; systemic
1.4
14.1
1367
11612
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
14.0
133
601
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
14.0
280
1683
L14
ICPC
Leg/thigh symptom/complaint
2.1
14.0
166
828
A01
ICPC
Pain general/multiple sites
2.1
14.0
170
856
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
14.0
252
1465
N03AX12
ATC
gabapentin; oral
1.7
13.9
321
2012
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
13.9
151
724
N30.0
ICD-10 Finland
Acute cystitis
1.7
13.8
317
1984
J01AA02
ATC
doxycycline; systemic
1.4
13.8
1784
15908
M05BA04
ATC
alendronic acid; oral
2.1
13.8
158
779
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
13.8
151
730
R03DC03
ATC
montelukast; oral
1.6
13.7
377
2479
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
13.7
179
929
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
13.7
197
1060
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
13.7
107
437
WW500
NOMESCO Finland
Blood transfusion
2.6
13.6
96
371
D68.1
ICD-10 Finland
Hereditary factor XI deficiency
+∞
13.5
13
*
2BD06
NOMESCO Finland
NA
+∞
13.5
13
*
R31
ICD-10 Finland
Unspecified haematuria
1.9
13.5
201
1093
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
13.5
122
539
A11CC03
ATC
alfacalcidol; systemic
3.6
13.4
59
165
XF402
NOMESCO Finland
ECG with work load test
1.9
13.3
213
1191
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
13.2
137
643
H02AB04
ATC
methylprednisolone; systemic
1.7
13.2
322
2049
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
13.2
197
1075
S16
ICPC
Bruise/contusion
2.9
13.2
81
287
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
13.2
325
2077
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.1
13.1
73
244
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
15.1
13.1
21
14
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
12.9
125
569
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.6
12.9
57
160
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
12.9
56
155
R53
ICD-10 Finland
Malaise and fatigue
1.5
12.8
454
3171
B83
ICPC
Purpura/coagulation defect
50.2
12.8
15
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
12.8
415
2838
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
12.8
174
916
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
12.8
161
821
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.0
12.8
73
246
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
12.7
374
2497
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.1
12.7
68
221
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
12.7
371
2475
N05CF01
ATC
zopiclone; oral
1.4
12.7
654
4940
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
12.6
88
339
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.1
12.5
68
224
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
12.5
12
*
G47.3
ICD-10 Finland
Sleep apnoea
1.5
12.5
408
2795
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.4
12.4
59
176
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
12.4
179
966
R07.3
ICD-10 Finland
Other chest pain
1.9
12.4
194
1077
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
12.4
102
430
L04AD01
ATC
ciclosporin; systemic
3.6
12.3
55
156
XF620
NOMESCO Finland
Examination of circulation with color method
8.0
12.3
27
34
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
12.3
68
227
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
12.2
200
1126
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
12.2
832
6601
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
12.2
187
1031
P01AB01
ATC
metronidazole; oral, rectal
1.4
12.2
884
7091
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
12.1
158
819
127
Kela drug reimbursment
Transplant complication
4.2
12.1
45
109
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.4
12.1
100
422
R06AX27
ATC
desloratadine; oral
1.4
12.1
631
4773
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
12.1
434
3037
X58
ICD-10 Finland
Exposure to other specified factors
1.6
12.1
292
1854
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
12.0
896
7216
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
3.1
12.0
64
208
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
12.0
161
844
ZXD35
NOMESCO Finland
Usual procedure
2.6
11.9
84
326
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
1.6
11.9
371
2510
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
11.8
191
1073
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
11.8
104
455
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
11.7
350
2345
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
11.7
211
1228
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
11.7
106
470
J01CA04
ATC
amoxicillin; systemic
1.4
11.6
1938
17713
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
11.6
170
922
C03DA01
ATC
spironolactone; oral
1.8
11.6
205
1185
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.4
11.6
41
95
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
11.6
106
473
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
11.6
183
1018
R02
ICPC
Shortness of breath/dyspnoea
1.7
11.5
247
1517
C01AA05
ATC
digoxin; systemic
2.0
11.5
147
756
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
5.9
11.5
31
53
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.0
11.5
153
799
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.8
11.5
218
1288
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.0
11.5
45
115
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
11.4
131
646
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
11.3
150
781
K90
ICPC
Stroke/cerebrovascular accident
3.0
11.3
63
212
WX722
NOMESCO Finland
PEEP
2.3
11.3
104
465
N96
ICD-10 Finland
Habitual aborter
4.9
11.3
36
75
H02AB09
ATC
hydrocortisone; systemic
3.0
11.3
62
207
R01AD09
ATC
mometasone; nasal
1.3
11.3
1021
8464
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
11.2
82
325
M03BX02
ATC
tizanidine; oral
1.3
11.2
1391
12090
205
Kela drug reimbursment
Chronic hypertension
1.5
11.1
494
3615
S97
ICPC
Chronic ulcer skin
2.2
11.1
110
509
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.0
11.1
43
109
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.7
11.1
249
1546
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
11.0
479
3485
A08
ICPC
Swelling
2.4
11.0
94
405
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
11.0
122
593
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
11.0
180
1013
6BA02
NOMESCO Finland
NA
13.9
11.0
18
13
K92.0
ICD-10 Finland
Haematemesis
3.2
10.9
56
178
J01MA06
ATC
norfloxacin; oral
1.6
10.8
290
1888
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.2
10.8
55
174
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
10.8
133
674
S06.0
ICD-10 Finland
Concussion
1.7
10.8
230
1407
2BD01
NOMESCO Finland
NA
17.9
10.7
16
9
C10AA05
ATC
atorvastatin; oral
1.4
10.7
656
5088
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
10.7
236
1460
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.6
10.7
46
128
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
10.7
231
1423
A02BA02
ATC
ranitidine; systemic
1.5
10.6
390
2738
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
10.6
267
1711
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
10.6
130
658
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.8
10.5
34
72
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.5
10.5
84
349
S18
ICPC
Laceration/cut
1.4
10.5
831
6723
C09AA05
ATC
ramipril; oral
1.5
10.5
434
3122
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
10.5
53
167
I81
ICD-10 Finland
Portal vein thrombosis
9.2
10.5
21
23
B99
ICPC
Blood/lymph/spleen disease other
7.3
10.5
24
33
194
Kela drug reimbursment
Blood coagulation factor VIII and von Willebrand factor for the treatment of von Willebrand disease
+∞
10.4
10
*
R52.2
ICD-10 Finland
Other chronic pain
2.5
10.4
80
325
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
10.4
41
106
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.8
10.3
171
967
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
10.3
69
261
G44.2
ICD-10 Finland
Tension-type headache
1.6
10.2
297
1975
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
10.2
172
982
N06AB04
ATC
citalopram; systemic
1.4
10.2
468
3440
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
10.2
97
443
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
10.2
365
2548
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.6
10.1
75
299
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
10.1
448
3268
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.5
10.1
79
327
S22.3
ICD-10 Finland
Fracture of rib
2.0
10.1
128
659
N06AA09
ATC
amitriptyline; systemic
1.7
10.0
205
1238
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
10.0
90
398
O02.1
ICD-10 Finland
Missed abortion
1.9
10.0
140
747
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
10.0
321
2185
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
10.0
142
764
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.3
10.0
89
391
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.5
10.0
77
314
R4190
NOMESCO Finland
Nutritional therapy
2.4
9.9
81
343
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
9.9
83
354
C09CA06
ATC
candesartan; oral
1.5
9.9
417
3013
3A064
NOMESCO Finland
NA
12.2
9.8
17
14
207
Kela drug reimbursment
Chronic arrhythmias
1.6
9.8
243
1550
Z86.7
ICD-10 Finland
Personal history of diseases of the circulatory system
26.1
9.8
13
5
J01FA09
ATC
clarithromycin; systemic
1.4
9.8
678
5360
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
9.7
318
2171
L01
ICPC
Neck symptom/complaint
1.6
9.7
292
1955
W84
ICPC
Pregnancy high risk
2.2
9.7
94
432
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
9.7
248
1594
-60
ICPC
Result test/procedure
2.0
9.7
129
674
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
3.9
9.7
38
98
L04AA01
ATC
[U] ciclosporin; systemic
3.5
9.6
44
129
M10.9
ICD-10 Finland
Gout, unspecified
2.0
9.6
114
572
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.8
9.6
21
27
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
9.6
146
804
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
9.6
377
2685
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
9.5
159
905
R52.9
ICD-10 Finland
Pain, unspecified
1.8
9.5
178
1048
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
5.7
9.5
26
46
TAB00
NOMESCO Finland
Lumbar puncture
2.1
9.5
102
492
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
9.5
169
982
RS221
NOMESCO Finland
NA
3.5
9.4
42
121
J20
ICD-10 Finland
Acute bronchitis
1.7
9.4
206
1272
RS230
NOMESCO Finland
NA
7.6
9.4
21
28
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
9.4
141
774
2869X
ICD-9 Finland
Coagulation defects, Other and unspecified coagulation defects
+∞
9.4
9
*
B02BD06
ATC
von Willebrand factor and coagulation factor VIII in combination; parenteral, topical, urethral
+∞
9.4
9
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
9.3
155
879
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.3
1050
8904
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
9.3
230
1466
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
9.3
118
609
I50
ICD-10 Finland
Heart failure
2.8
9.3
58
210
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.5
9.2
73
303
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.1
9.2
100
484
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
9.2
410
2992
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
9.2
182
1090
M79.1
ICD-10 Finland
Myalgia
1.6
9.2
271
1807
J01EA01
ATC
trimethoprim; systemic
1.4
9.2
540
4145
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.0
9.1
50
168
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
9.1
200
1236
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
9.1
72
298
R01AD05
ATC
budesonide; nasal
1.8
9.1
166
970
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
9.1
285
1925
SBB10
NOMESCO Finland
Teeth copy
1.8
9.1
148
835
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
9.1
119
622
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
9.1
251
1650
J02AC01
ATC
fluconazole; systemic
1.3
9.1
922
7700
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
9.0
277
1863
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.0
9.0
34
85
C08CA02
ATC
felodipine; oral
1.8
9.0
165
967
R4130
NOMESCO Finland
Speech therapy
2.9
9.0
52
180
XQ800
NOMESCO Finland
Prick test
1.7
9.0
168
991
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
8.9
100
491
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.5
8.9
374
2695
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
5.5
8.9
25
46
A28
ICPC
Limited function/disability NOS
1.6
8.9
256
1696
C08CA01
ATC
amlodipine; oral
1.4
8.9
605
4753
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
8.8
282
1915
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
8.8
138
767
N05BA04
ATC
oxazepam; oral
1.4
8.8
513
3923
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.0
8.8
48
161
R05
ICD-10 Finland
Cough
1.4
8.8
381
2760
I50.1
ICD-10 Finland
Left ventricular failure
2.3
8.8
80
359
L05
ICPC
Flank/axilla symptom/complaint
2.0
8.8
112
579
R01AD08
ATC
fluticasone; nasal
1.4
8.8
608
4789
S20.2
ICD-10 Finland
Contusion of thorax
2.1
8.8
99
489
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
5.4
8.7
25
47
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.3
8.7
79
353
A02BC03
ATC
lansoprazole; oral
1.4
8.7
574
4482
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.7
8.7
28
60
SPAT1255
SPAT
Intravenous administration of medicine
1.9
8.7
127
691
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.9
8.6
115
604
SPAT1260
SPAT
Consultation of another employee
1.5
8.6
360
2588
R81
ICPC
Pneumonia
2.3
8.6
73
316
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
8.6
78
348
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
8.6
485
3692
K29
ICPC
Cardiovascular sympt/complt other
2.2
8.6
86
403
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
8.6
275
1872
R1260
NOMESCO Finland
Evaluation of communicative skills
3.6
8.5
37
105
H53.4
ICD-10 Finland
Visual field defects
2.9
8.5
49
169
WX872
NOMESCO Finland
Intensive care
2.1
8.5
92
444
C07AA05
ATC
propranolol; systemic
1.4
8.5
411
3042
D07AC01
ATC
betamethasone; topical
1.3
8.5
683
5501
N06AX11
ATC
mirtazapine; oral
1.3
8.5
649
5186
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
8.5
69
293
WZC30
NOMESCO Finland
Teaching
1.6
8.5
243
1610
N02AC04
ATC
dextropropoxyphene; oral
2.4
8.5
71
304
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
8.5
103
522
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
8.5
153
891
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
8.5
144
823
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
2.9
8.5
50
177
J01DA06
ATC
[U] cefuroxime; systemic
1.5
8.5
310
2171
C08CA05
ATC
nifedipine; systemic
1.9
8.4
129
712
WX610
NOMESCO Finland
Patient controlled analgesia
5.4
8.4
24
45
R03AC03
ATC
terbutaline; inhalant
1.5
8.4
300
2089
D69.5
ICD-10 Finland
Secondary thrombocytopenia
90.3
8.4
9
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
8.4
58
225
A06AD11
ATC
lactulose; oral
1.6
8.4
248
1655
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
8.4
210
1344
N03AF02
ATC
oxcarbazepine; oral
2.3
8.4
74
328
318
Kela drug reimbursment
Teriparatide
7.9
8.4
18
23
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
8.3
8
*
K60
ICPC
Cardiovascular, Result test/procedure
5.0
8.3
25
50
C01DA14
ATC
isosorbide mononitrate; oral
1.5
8.3
253
1702
K08.3
ICD-10 Finland
Retained dental root
1.8
8.3
134
756
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
8.3
157
931
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
8.3
83
387
A07DA03
ATC
loperamide; oral
2.3
8.3
73
323
N03AX09
ATC
lamotrigine; oral
1.9
8.3
110
579
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.5
8.3
64
265
E66.8
ICD-10 Finland
Other obesity
1.9
8.2
120
653
N05CF02
ATC
zolpidem; oral
1.4
8.2
360
2616
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.4
8.2
69
296
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
14.5
8.2
13
9
WX890
NOMESCO Finland
Intesive care monitoring
5.1
8.2
24
47
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
8.1
115
618
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
8.1
87
420
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.6
8.1
57
225
H05AA02
ATC
teriparatide; parenteral
8.1
8.1
17
21
WW400
NOMESCO Finland
Plasmaferesis
17.2
8.1
12
7
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
8.0
495
3822
N03AE01
ATC
clonazepam; systemic
1.9
8.0
112
600
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.0
174
1071
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.9
8.0
47
166
ZX108
NOMESCO Finland
Inhalation
5.3
8.0
23
44
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.4
8.0
65
276
J05AB11
ATC
valaciclovir; oral
1.5
8.0
269
1852
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
7.9
231
1535
J01FA15
ATC
telithromycin; oral
1.6
7.9
202
1299
R4150
NOMESCO Finland
Neuropsychological rehabilitation
4.4
7.9
27
62
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
7.9
278
1931
C01BD01
ATC
amiodarone; systemic
2.7
7.9
52
198
ZXE90
NOMESCO Finland
More than 22 hours
4.9
7.9
24
49
4538X
ICD-9 Finland
Other venous embolism and thrombosis, Of other specified veins
13.1
7.9
13
10
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.8
7.9
17
22
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.5
7.9
26
58
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.8
591
4706
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
7.8
184
1162
ZY010
NOMESCO Finland
Hospital outpatient
1.9
7.8
118
649
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.5
7.8
229
1526
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.5
7.8
238
1603
UKC02
NOMESCO Finland
Cystoscopy
1.5
7.8
275
1910
XX9XW
NOMESCO Finland
NA
4.8
7.7
24
50
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
7.7
191
1220
XLA10
NOMESCO Finland
NA
1.9
7.7
108
579
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.2
7.7
39
125
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.6
7.7
203
1318
TGC00
NOMESCO Finland
Bronchial lavation
2.8
7.7
47
171
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
45.1
7.7
9
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.2
7.7
72
328
A12BA01
ATC
potassium chloride; oral
2.1
7.7
82
396
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
7.7
195
1254
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.1
7.7
28
69
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
7.4
7.7
17
23
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
7.4
7.7
17
23
WX882
NOMESCO Finland
High dependency care
2.5
7.7
58
239
M54.5
ICD-10 Finland
Low back pain
1.3
7.6
685
5592
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.3
7.6
36
110
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.2
7.6
71
322
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.4
7.6
35
105
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
7.6
226
1512
R04.2
ICD-10 Finland
Haemoptysis
2.4
7.6
63
271
W10
ICD-10 Finland
Fall on and from stairs and steps
1.9
7.6
99
519
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
18.4
7.6
11
6
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
7.6
107
577
G03DB01
ATC
dydrogesterone; oral
1.5
7.6
298
2119
742
NOMESCO Finland
NA
11.9
7.6
13
11
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.3
7.6
36
111
XMA22
NOMESCO Finland
General examination of pregnant woman
1.7
7.5
145
865
PG1UT
NOMESCO Finland
Percutaneous aspiration throbectomy
8.9
7.5
15
17
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.9
7.5
15
17
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
1.9
7.5
108
584
A91
ICPC
Abnormal result investigation NOS
2.1
7.5
83
407
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
7.5
1590
14459
A12AA04
ATC
calcium carbonate; oral
3.5
7.5
33
96
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
2.2
7.5
73
340
Z00.0
ICD-10 Finland
General medical examination
1.4
7.5
363
2686
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.0
7.5
41
140
A07AA02
ATC
nystatin; oral
1.8
7.4
119
670
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
7.4
135
791
D69.4
ICD-10 Finland
Other primary thrombocytopenia
80.3
7.4
8
*
R03BB04
ATC
tiotropium bromide; inhalant
1.6
7.4
175
1106
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
7.4
265
1845
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.7
7.4
145
868
SPAT1263
SPAT
Sampling
1.3
7.4
914
7779
WX730
NOMESCO Finland
Conventional respirator
3.2
7.4
36
113
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
13.4
7.4
12
9
M35.1
ICD-10 Finland
Other overlap syndromes
6.0
7.4
19
32
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
7.4
314
2266
J01CA08
ATC
pivmecillinam; oral
1.3
7.4
887
7525
E87.6
ICD-10 Finland
Hypokalaemia
2.4
7.4
58
243
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
7.3
120
680
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
7.3
97
512
R11
ICD-10 Finland
Nausea and vomiting
1.6
7.3
166
1038
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.4
7.3
25
654
RS222
NOMESCO Finland
NA
3.4
7.3
33
98
2860A
ICD-9 Finland
Coagulation defects, Congenital factor VIII disorder
+∞
7.3
7
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
7.3
218
1461
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
7.3
58
245
L01XX05
ATC
hydroxycarbamide; oral
4.2
7.3
26
63
L04AA13
ATC
leflunomide; oral
2.5
7.3
54
218
D45
ICD-10 Finland
Polycythaemia vera
4.9
7.3
22
45
N06AX21
ATC
duloxetine; oral
1.5
7.3
216
1444
L12
ICPC
Hand/finger symptom/complaint
1.5
7.2
281
1991
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
7.2
54
220
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
7.2
102
552
R03BA08
ATC
ciclesonide; inhalant
1.6
7.2
160
996
N05BA01
ATC
diazepam; systemic, rectal
1.5
7.2
254
1763
L29
ICPC
Musculoskeletal sympt/complt other
1.7
7.2
140
840
B28
ICPC
Limited function/disability (B)
7.3
7.2
16
22
RD210
NOMESCO Finland
NA
2.7
7.2
46
171
N18.0
ICD-10 Finland
End-stage renal disease
3.9
7.2
27
69
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.0
7.1
87
445
I82.1
ICD-10 Finland
Thrombophlebitis migrans
30.1
7.1
9
*
D07AB08
ATC
desonide; topical
1.5
7.1
220
1484
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
4.2
7.1
25
60
R03BA01
ATC
beclometasone; inhalant
1.5
7.1
282
2008
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.1
142
856
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.0
7.1
12
10
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.8
7.1
43
157
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.6
7.1
47
181
I74.2
ICD-10 Finland
Embolism and thrombosis of arteries of upper extremities
10.0
7.0
13
13
K07.60
ICD-10 Finland
Snapping jaw
1.8
7.0
108
601
R01AD12
ATC
fluticasone furoate; nasal
1.3
7.0
636
5187
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
4.3
7.0
24
56
AN1
HP
Coronary angiography
1.6
7.0
191
1253
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
7.0
7.0
16
23
J45
ICD-10 Finland
Asthma
1.6
7.0
198
1309
C03AA03
ATC
hydrochlorothiazide; oral
1.6
7.0
158
989
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.6
7.0
47
183
TPH00
NOMESCO Finland
Phlebotomy
6.3
6.9
17
27
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
6.9
157
980
R5599
NOMESCO Finland
Other rehabilitation service
2.3
6.9
59
259
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
5.5
6.9
19
35
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.5
6.9
19
35
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
5.8
6.9
18
31
K84
ICPC
Heart disease other
2.5
6.9
52
214
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.4
6.8
52
215
M05BX04
ATC
denosumab; parenteral
2.0
6.8
78
389
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.8
6.8
21
44
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.7
6.8
42
155
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
8.3
6.8
14
17
UJH02
NOMESCO Finland
Anoscopy
2.0
6.8
82
417
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
6.8
230
1585
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
6.8
51
207
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
6.8
136
819
WW200
NOMESCO Finland
Immunization
2.2
6.8
64
295
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
2.1
6.8
75
368
J05AB01
ATC
aciclovir; systemic
1.4
6.8
428
3310
I82.80
ICD-10 Finland
Emboli and thrombosis in the subclavian vein
9.3
6.8
13
14
R52.0
ICD-10 Finland
Acute pain
2.1
6.8
70
333
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.0
6.8
25
63
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
6.8
52
217
JAH00
NOMESCO Finland
Laparotomy
2.4
6.8
54
228
PD4ST
NOMESCO Finland
Endovascular thrombolysis of pelvic and lower extremity arteries
16.7
6.7
10
6
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.9
6.7
39
137
R1250
NOMESCO Finland
Evaluation of functional capability
2.5
6.7
48
192
R5110
SPAT
NA
2.4
6.7
52
218
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.4
6.7
51
211
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
6.7
90
479
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
6.7
125
740
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
6.7
123
724
PH2AE
SPAT
NA
3.1
6.7
34
111
R06AE09
ATC
levocetirizine; oral
1.4
6.7
301
2195
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.4
6.7
52
219
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.9
6.7
89
469
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.8
6.7
112
640
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.6
310
2278
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
6.4
6.6
16
25
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
6.4
6.6
16
25
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
3.1
6.6
34
112
M05BA07
ATC
risedronic acid; oral
2.3
6.6
56
244
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.7
6.6
43
163
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.5
6.6
47
188
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.7
6.6
134
812
C10AA03
ATC
pravastatin; oral
1.8
6.6
115
666
N25.0
ICD-10 Finland
Renal osteodystrophy
12.3
6.6
11
9
M01AH02
ATC
rofecoxib; oral
1.5
6.6
227
1572
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
6.6
50
207
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.6
6.6
43
164
K01.0
ICD-10 Finland
Embedded teeth
2.5
6.6
47
189
SPAT1104
SPAT
Monitoring of emergency patient
1.7
6.5
125
744
RS220
NOMESCO Finland
NA
3.0
6.5
34
113
O22.0
ICD-10 Finland
Varicose veins of lower extremity in pregnancy
10.0
6.5
12
12
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
6.5
235
1642
J01.4
ICD-10 Finland
Acute pansinusitis
4.3
6.5
22
51
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.5
836
7122
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
6.5
178
1168
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.8
6.5
105
594
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
6.5
119
700
M10.0
ICD-10 Finland
Idiopathic gout
2.3
6.5
56
249
A60
ICPC
General and Unspecified, Result test/procedure
1.9
6.4
88
472
JN4CD
NOMESCO Finland
Very extensive body CT
2.1
6.4
71
351
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
6.4
186
1235
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
6.4
68
329
M79.7
ICD-10 Finland
Fibromyalgia
2.1
6.4
70
342
E000006
ATC
NA
1.7
6.4
136
836
ZZA00
NOMESCO Finland
Split skin graft
2.3
6.4
56
250
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
2.1
6.4
65
307
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
6.4
72
356
O22.8
ICD-10 Finland
Other venous complications in pregnancy
14.3
6.4
10
7
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
6.4
323
2408
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.8
6.4
95
526
E000003
ATC
NA
1.9
6.3
91
497
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.7
6.3
130
792
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.6
6.3
140
873
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
6.0
6.3
16
27
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
6.0
6.3
16
27
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
6.3
84
444
A04
ICPC
Weakness/tiredness general
1.4
6.3
262
1883
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
6.3
152
968
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.7
6.3
25
68
2867X
ICD-9 Finland
Coagulation defects, Acquired coagulation factor deficiency[DEFECTIO COAGULATIONIS, E DEFICIENTIA NON DEFINITA]
+∞
6.3
6
*
28600
ICD-8 Finland
Coagulation defects, Haemophilia
+∞
6.3
6
*
M362, D66
ICD-10 Finland
NA
+∞
6.3
6
*
C02KX05
ATC
riociguat; oral
+∞
6.3
6
*
O991, D688
ICD-10 Finland
NA
+∞
6.3
6
*
D67
ICD-10 Finland
Hereditary factor IX deficiency
+∞
6.3
6
*
2BDXX
NOMESCO Finland
NA
+∞
6.3
6
*
O991, D680
ICD-10 Finland
NA
+∞
6.3
6
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
6.2
82
433
PBE09
NOMESCO Finland
Thrombectomy or embolectomy of brachial artery
26.7
6.2
8
*
I82.0
ICD-10 Finland
Budd-Chiari syndrome
26.7
6.2
8
*
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.8
6.2
19
40
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
7.0
6.2
14
20
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.5
6.2
207
1423
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
6.2
67
329
H53.2
ICD-10 Finland
Diplopia
2.2
6.2
57
261
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
6.2
106
610
N19
ICD-10 Finland
Unspecified kidney failure
2.3
6.2
54
241
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.7
6.2
38
141
TK810
NOMESCO Finland
Hemofiltration
5.0
6.2
18
36
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.8
6.2
24
64
D06
ICPC
Abdominal pain localized other
1.6
6.2
168
1104
T14.0
ICD-10 Finland
Superficial injury of unspecified body region
3.3
6.1
28
85
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
3.1
6.1
30
96
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.1
6.1
66
323
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
6.1
200
1369
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.0
6.1
68
337
R05
ICPC
Cough
1.3
6.1
444
3503
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.1
739
6242
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
6.1
812
6937
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.8
6.1
36
130
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
6.1
74
378
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
3.7
6.1
24
65
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
1.8
6.1
105
608
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.6
6.1
41
161
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.1
576
4720
GD1LA
NOMESCO Finland
GD
3.4
6.0
27
81
ZXE80
NOMESCO Finland
More than 18 and less than 21 hours
10.0
6.0
11
11
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
6.0
305
2270
J01MA01
ATC
ofloxacin; systemic
1.6
6.0
151
972
JN4AD
NOMESCO Finland
Body CT examination
1.7
6.0
120
725
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
363
374
10.96
320.42
1.9
1.2
u/ml
12.9
3.6
3.77
149
123
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1123
3172
5.17
307.65
5.4
2.1
s
33.4
29.7
23.70
1089
3062
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
665
644
13.13
307.65
4.8
2.8
g/l
3.3
3.6
3.98
625
608
(3036489) Thrombin time
750
848
11.61
307.65
4.2
2.3
s
21.7
21.2
0.71
630
728
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
811
633
17.46
307.65
5.5
2.7
%
149.2
182.2
13.04
770
605
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
668
717
11.83
307.65
4.5
2.5
%
96.9
92.0
4.75
626
664
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
339
363
10.45
290.47
1.9
1.2
u/ml
10.2
3.9
4.67
169
155
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
185
69
28.59
273.33
1.4
1.1
%
97.8
110.5
1.49
170
63
(3033658) Prothrombin time (PT) actual/Normal
1382
5603
3.82
270.72
7.0
3.7
%
85.2
92.2
12.09
1337
5447
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
325
374
9.67
263.40
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
135
18
78.65
252.58
1.6
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
310
364
9.43
247.06
1.2
1.1
%
113.0
117.7
1.18
287
335
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1280
5266
3.58
238.73
3.8
1.7
mg/l
1.3
1.0
1.63
968
3973
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
166
68
25.85
236.93
1.4
1.1
%
90.3
90.3
0.00
94
34
(4306422)
306
381
8.87
232.55
1.3
1.2
—
—
—
0
0
(4268621)
253
244
11.27
232.47
3.4
2.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
195
122
17.07
231.44
1.6
2.8
%
98.4
97.6
0.08
179
114
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
164
72
24.10
227.93
1.2
1.1
%
91.3
87.6
0.45
90
36
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
369
642
6.45
206.98
6.0
3.2
u/ml
0.3
0.4
0.69
236
352
(3032080) INR in Blood by Coagulation assay
1625
8332
3.19
200.89
23.3
8.4
inr
1.6
1.2
28.11
543
2507
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
238
261
9.85
199.08
1.2
1.1
%
87.3
95.7
2.96
223
250
(3012095) Magnesium [Moles/volume] in Serum or Plasma
883
3371
3.34
176.97
4.8
3.4
mmol/l
0.8
0.8
0.47
843
3157
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
169
137
13.04
173.15
1.5
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
724
2512
3.52
168.26
47.3
22.9
inr
1.8
1.3
6.71
57
379
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
112
43
27.06
163.17
1.2
1.2
%
77.0
70.0
0.37
40
11
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
110
43
26.56
159.21
1.2
1.1
%
88.3
82.2
0.45
44
11
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
732
2900
3.04
133.13
3.9
2.5
%
22.9
23.2
0.17
683
2482
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
619
2264
3.21
128.87
4.4
3.9
u/l
235.6
243.6
0.60
598
2138
(3004789) Transferrin [Mass/volume] in Serum or Plasma
760
3137
2.93
127.76
3.7
2.4
g/l
2.3
2.4
1.14
720
2914
(3034426) Prothrombin time (PT)
109
78
14.49
119.80
1.5
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
787
3451
2.76
116.72
3.8
2.4
umol/l
13.2
13.5
0.64
753
3191
(3022096) Basophils/100 leukocytes in Blood
1685
10644
2.41
112.46
8.5
5.9
%
0.7
0.7
0.13
1602
9927
(42870588) Differential panel, method unspecified - Blood
1344
7738
2.38
110.31
7.8
5.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1715
10977
2.39
110.18
8.5
5.8
%
2.8
2.8
0.54
1631
10218
(3006315) Basophils [#/volume] in Blood
1791
11736
2.40
108.21
8.3
5.7
e9/l
0.0
0.0
0.36
1561
10185
(3019069) Monocytes/100 leukocytes in Blood
1715
11041
2.37
107.76
8.8
6.1
%
8.5
8.4
0.75
1634
10349
(3001604) Monocytes [#/volume] in Blood
1782
11696
2.38
106.58
8.3
5.7
e9/l
0.6
0.6
0.29
1554
10155
(3013115) Eosinophils [#/volume] in Blood
1824
12138
2.38
104.97
8.6
6.0
e9/l
0.2
0.2
0.34
1621
10744
(3019198) Lymphocytes [#/volume] in Blood
1808
12052
2.35
102.62
8.4
5.8
e9/l
1.9
1.9
1.74
1596
10713
(3024561) Albumin [Mass/volume] in Serum or Plasma
1501
9341
2.27
99.20
6.4
4.6
g/l
35.6
35.8
0.56
1414
8691
(3002030) Lymphocytes/100 leukocytes in Blood
1725
11382
2.29
98.69
8.6
5.9
%
27.5
28.4
2.66
1639
10639
(3018010) Neutrophils/100 leukocytes in Blood
1703
11218
2.27
97.25
8.4
5.7
%
58.0
57.1
2.34
1625
10516
(3018418) pH of Serum or Plasma
1114
6333
2.24
89.34
5.8
3.8
ph
7.4
7.4
0.57
226
1205
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
265
700
4.07
89.16
3.2
1.8
g/l
0.2
0.2
3.07
255
662
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
124
166
7.76
87.68
1.6
1.1
ratio
1.2
1.0
3.20
53
70
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
269
727
3.98
87.66
3.1
1.7
g/l
1.1
1.2
1.16
259
689
(3037522) Nuclear Ab [Titer] in Serum
694
3287
2.47
84.41
1.6
1.3
titre
655.8
563.2
0.51
162
677
(3013650) Neutrophils [#/volume] in Blood by Automated count
1894
13485
2.19
83.04
11.3
8.5
e9/l
4.1
4.1
0.17
1674
11818
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1490
9713
2.11
81.99
9.3
5.8
mmol/l
1.2
1.2
1.18
1399
8817
(3030467) Casts [#/volume] in Urine by Automated count
1057
6094
2.16
79.81
4.2
3.0
e6/l
0.4
0.4
0.01
816
4609
(3021589) Normoblasts [#/volume] in Blood
1548
10366
2.07
77.70
13.7
8.8
e9/l
0.0
0.0
1.05
1253
8450
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1666
11464
2.08
77.58
7.2
5.7
umol/l
11.5
11.1
0.61
1592
10839
(40758558) Short blood count panel - Blood
1012
5806
2.15
76.75
7.9
6.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1589
10773
2.06
76.73
9.5
6.4
mmol/l
1.2
1.2
1.31
1363
9099
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
762
3906
2.29
76.43
3.5
2.8
mmol/l
2.4
2.4
0.78
685
3419
(3002582) Erythrocytes [#/volume] in Urine
1120
6688
2.11
76.37
4.4
3.1
e6/l
43.4
98.6
1.50
878
5127
(3027945) Reticulocytes/100 erythrocytes in Blood
529
2305
2.59
76.09
3.7
2.5
%
1.9
1.8
1.03
466
2063
(36304419) Bacteria [Presence] in Urine
1033
6020
2.12
74.79
4.2
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1264
8009
2.03
72.25
5.1
3.6
e6/l
54.6
100.6
2.33
918
5560
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1012
5913
2.10
72.24
3.2
2.2
mg/l
3.1
2.9
1.48
886
5074
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2221
17308
2.25
71.09
10.4
7.0
u/l
77.1
76.8
0.11
2122
16309
(3015377) Calcium [Moles/volume] in Serum or Plasma
1191
7445
2.02
70.15
3.8
3.2
mmol/l
2.3
2.3
0.65
1078
6593
(3009445) Proteinase 3 Ab [Units/volume] in Serum
273
875
3.34
68.49
1.6
1.5
u/ml
5.2
10.1
—
9
20
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
235
691
3.61
67.39
1.7
1.6
titre
105.0
145.9
0.46
12
27
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
98
141
7.16
64.93
1.5
1.1
u/ml
69.2
31.7
0.48
16
13
(3026782) Osmolality of Urine
791
4357
2.13
64.74
3.6
2.7
mosm/kgh2o
529.2
543.6
1.07
684
3690
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
81
94
8.84
64.32
1.4
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1760
13014
1.91
59.20
7.0
4.6
mmol/l
6.5
6.6
2.41
1675
12057
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
731
4041
2.08
58.39
4.6
3.6
ng/l
311.2
382.8
0.27
539
2872
(3023368) Bacteria identified in Blood by Culture
928
5640
1.95
56.43
6.1
4.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
84
121
7.12
55.58
1.1
1.1
%
90.1
92.0
0.20
70
96
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
637
3429
2.10
54.11
3.7
2.8
e6/l
2.6
2.8
0.25
331
1855
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1559
11281
1.83
54.03
4.3
2.8
ug/l
111.9
100.7
0.89
1474
10533
(3023420) DNA double strand Ab [Units/volume] in Serum
118
244
5.00
53.83
2.3
1.7
iu/ml
38.6
26.2
0.90
21
18
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1005
6357
1.89
53.57
2.8
2.1
u/l
181.3
205.9
0.48
971
5996
(3000850) Epithelial cells [#/volume] in Urine
798
4702
1.97
52.47
3.5
2.5
e6/l
5.7
6.7
1.01
714
4116
(3020779) Urea [Moles/volume] in Serum or Plasma
399
1796
2.42
52.20
9.9
7.5
mmol/l
9.6
9.3
0.29
380
1712
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
386
1732
2.42
50.78
2.8
2.6
ml/min/173m2
78.3
69.0
5.81
262
676
(3003458) Phosphate [Moles/volume] in Serum or Plasma
534
2777
2.13
49.19
8.6
5.7
mmol/l
1.0
1.0
0.63
505
2581
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
500
2557
2.16
47.99
3.4
2.6
umol/l
7.5
7.5
0.01
439
2199
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1136
7677
1.79
47.47
3.8
3.1
u/l
30.6
32.1
0.75
1080
7308
(3044640) Blood type and Crossmatch panel - Blood
1098
7353
1.80
47.26
3.3
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
356
1589
2.42
47.22
2.8
2.7
g/l
66.2
66.6
0.46
334
1464
(3004588) Protein electrophoresis panel - Serum or Plasma
308
1295
2.54
46.45
2.5
2.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
238
891
2.82
45.15
2.5
1.8
g/l
1.4
1.5
1.05
210
782
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
641
3667
1.96
44.99
3.4
2.6
e6/l
0.7
1.2
3.23
337
2083
(3026493) Urate [Moles/volume] in Serum or Plasma
893
5699
1.82
44.55
3.4
2.5
umol/l
1550.1
5162.1
4.09
784
4979
(3013707) Erythrocyte sedimentation rate by Westergren method
2103
17201
1.83
43.48
5.7
3.9
mm/h
12.9
11.4
4.23
1993
15969
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
176
567
3.24
43.45
2.6
2.5
g/l
0.2
0.0
0.44
162
526
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
866
5519
1.81
43.14
3.7
3.0
ng/l
1613.1
1361.5
0.98
729
4655
(3015171) Extractable nuclear Ab [Units/volume] in Serum
242
936
2.73
43.10
1.4
1.3
u/ml
0.3
1.0
—
10
84
(3005719) IgG [Mass/volume] in Serum or Plasma
365
1713
2.30
42.97
3.2
2.7
g/l
10.5
10.6
0.22
345
1573
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
256
1021
2.65
42.91
7.0
4.3
mmol/l
24.1
24.0
0.32
233
930
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
168
531
3.30
42.78
2.4
2.5
g/l
0.0
0.0
0.50
154
492
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
167
527
3.30
42.63
2.4
2.5
g/l
0.0
0.0
0.00
154
491
(3052851) Hemolysis interference index of Serum or Plasma
187
632
3.10
42.59
3.5
3.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
89
178
5.13
42.18
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
89
179
5.10
41.91
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
418
2104
2.15
41.34
3.0
2.4
u/l
77.6
60.3
0.13
369
1786
(40759836) Histone Ab [Presence] in Serum by Immunoblot
88
178
5.07
41.17
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
88
178
5.07
41.17
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
182
619
3.07
40.98
1.4
1.2
u/ml
6.5
2.7
0.89
24
68
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
175
582
3.14
40.95
2.4
2.4
g/l
37.0
37.6
0.72
157
511
(3000991) Gas panel - Venous blood
363
1733
2.25
40.93
13.1
8.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
88
179
5.04
40.91
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
88
179
5.04
40.91
1.3
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
475
2522
2.06
40.77
11.4
6.9
mmol/l
104.9
104.5
1.04
468
2461
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
185
639
3.03
40.55
2.7
2.6
g/l
0.6
1.1
1.46
164
568
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
194
689
2.95
40.47
3.5
2.3
ug/l
516.5
443.7
0.11
183
637
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
597
3442
1.93
40.45
2.1
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
53
65
8.29
40.23
1.6
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
301
1336
2.40
40.17
2.1
1.8
g/l
1.3
1.4
0.49
284
1232
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
207
765
2.84
40.15
3.1
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1922
15505
1.72
39.43
5.6
4.2
e6/l
256.9
1737.3
2.06
29
200
(3037467) Urinalysis macro (dipstick) panel - Urine
1985
16161
1.74
39.34
5.6
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
447
2350
2.07
39.30
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
444
2329
2.07
39.27
2.0
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
190
685
2.90
38.56
1.3
1.2
u/ml
64.0
30.7
0.75
15
44
(3023520) Reticulocytes [#/volume] in Blood
345
1660
2.23
38.04
3.7
2.5
e9/l
76.8
70.1
1.92
219
1259
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1461
11026
1.66
38.02
5.0
4.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
179
631
2.96
37.82
1.4
1.2
u/ml
16.6
8.2
0.60
33
106
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
192
709
2.83
37.26
2.5
2.5
g/l
3.3
3.1
1.02
161
560
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
60
93
6.57
37.08
1.4
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
188
695
2.82
36.40
2.4
2.5
g/l
10.6
10.3
0.37
166
597
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
197
750
2.75
36.07
2.5
2.5
g/l
3.7
3.8
0.17
161
544
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
197
751
2.74
35.98
2.5
2.5
g/l
7.2
7.4
0.89
163
575
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
197
751
2.74
35.98
2.5
2.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
156
524
3.09
35.86
1.3
1.2
u/ml
47.7
41.7
0.18
24
53
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
841
5559
1.73
35.65
3.1
2.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
355
1778
2.14
35.27
10.9
7.3
mmol/l
1.3
1.4
0.07
340
1702
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
147
487
3.13
34.59
1.2
1.2
u/ml
2.2
3.9
—
9
36
(3042936) Bacteria identified in Isolate by Culture
531
3140
1.85
32.53
2.4
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2306
19977
1.78
32.45
29.3
15.4
%
13.8
13.6
9.37
2277
19547
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
376
1987
2.03
32.21
2.6
2.2
g/l
0.2
0.2
0.12
354
1856
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
143
487
3.04
32.09
1.2
1.2
—
7.0
—
0
8
(3039162) Centromere protein B Ab [Units/volume] in Serum
106
301
3.62
31.86
1.3
1.3
u/ml
88.3
49.7
—
6
21
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
135
450
3.10
31.43
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
135
450
3.10
31.43
1.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
315
1599
2.09
30.01
4.8
3.8
ng/l
104.4
86.4
1.67
280
1403
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1096
8029
1.59
29.79
4.2
3.3
ng/l
37.4
45.1
0.43
662
4958
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1268
9633
1.57
29.28
2.9
2.2
nmol/l
76.6
76.0
0.35
1176
8750
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
152
565
2.78
29.09
3.5
3.5
ratio
8.1
1.7
0.43
11
50
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
321
1660
2.05
29.05
3.6
2.9
ng/l
281.3
196.6
1.93
288
1504
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
154
580
2.75
28.75
3.6
3.5
mg/l
29.6
82.9
1.48
129
479
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2600
23610
2.06
28.71
23.5
12.8
mg/l
22.6
22.4
0.09
2252
18516
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
228
1037
2.30
28.54
12.5
10.1
mmol/l
24.1
24.3
0.39
216
977
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
153
580
2.73
28.20
5.0
4.5
mg/l
1.6
1.5
0.54
145
542
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
404
2293
1.89
27.84
10.6
7.7
kpa
5.1
5.1
0.13
387
2190
(3027801) Oxygen [Partial pressure] in Arterial blood
404
2294
1.89
27.80
10.6
7.7
kpa
12.2
12.5
0.51
385
2193
(3007853) Bacteria identified in Skin by Aerobe culture
457
2699
1.82
27.75
2.3
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1172
8822
1.55
27.73
2.3
1.9
pmol/l
95.2
96.0
0.23
662
4655
(3034860) Kappa light chains.free [Mass/volume] in Serum
152
580
2.71
27.67
3.7
3.5
mg/l
47.6
65.8
0.69
128
479
(3007164) IgA [Mass/volume] in Serum or Plasma
726
4908
1.64
26.96
1.8
1.4
g/l
2.3
2.3
0.10
472
3051
(3003396) Base excess in Arterial blood by calculation
400
2291
1.87
26.73
10.5
7.7
mmol/l
0.6
1.0
1.16
328
1766
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
129
462
2.88
26.47
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
296
1553
2.01
25.63
1.8
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2591
23669
1.96
25.53
25.5
14.4
mmol/l
3.9
3.9
2.65
2549
23002
(3019550) Sodium [Moles/volume] in Serum or Plasma
2585
23596
1.95
25.53
25.3
14.3
mmol/l
139.4
139.6
2.62
2548
22968
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
385
2214
1.85
25.33
4.4
3.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
38
56
6.86
24.62
1.8
1.1
%
88.2
94.9
0.54
38
56
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
38
56
6.86
24.62
1.7
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
119
428
2.86
24.23
1.4
1.4
u/ml
120.5
113.1
0.16
22
75
(3016502) Oxygen saturation in Arterial blood
356
2031
1.86
23.95
11.4
8.3
%
95.6
95.6
0.00
342
1958
(3026008) Bacteria identified in Urine by Culture
923
6788
1.53
23.22
3.4
2.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
67
173
3.94
23.13
1.3
1.2
titre
98.8
207.5
—
8
32
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
240
1211
2.07
23.07
1.7
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
26
26
10.08
22.94
1.5
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1830
15495
1.50
22.84
4.3
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
178
801
2.30
22.79
1.4
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2406
21691
1.67
22.27
21.4
11.6
ml/min/173m2
84.5
84.7
0.13
2113
17827
(3002032) Base excess in Venous blood by calculation
335
1917
1.85
22.25
6.7
3.9
mmol/l
1.7
1.9
0.24
280
1521
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
119
449
2.72
22.16
3.9
3.6
%
59.1
57.8
0.55
119
449
(40767503) Oxygen content in Capillary blood by calculation
114
421
2.78
22.11
3.4
2.4
%
17.3
16.4
1.37
50
211
(3002173) Hemoglobin [Mass/volume] in Arterial blood
328
1880
1.84
21.65
12.2
8.6
g/l
120.9
121.7
0.28
318
1808
(3002179) Metamyelocytes/100 leukocytes in Blood
304
1711
1.87
21.25
4.8
3.8
%
0.6
0.6
0.06
67
372
(3021447) Carbon dioxide [Partial pressure] in Venous blood
332
1928
1.82
20.98
6.7
3.8
kpa
6.0
5.8
1.50
318
1868
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
212
1059
2.08
20.91
12.4
11.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
25
27
9.33
20.87
1.4
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
299
1684
1.87
20.84
5.3
4.1
%
0.1
0.5
0.67
75
395
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
643
4457
1.57
20.73
1.8
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
120
473
2.60
20.51
6.0
4.3
mmol/l
2.2
2.5
0.54
76
310
(40760888) Immunoglobulin light chains.free panel - Serum
114
438
2.67
20.50
3.7
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
373
2259
1.75
20.41
2.3
2.1
nmol/l
345.4
372.4
2.03
351
2073
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
78
243
3.27
20.38
1.1
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
614
4226
1.58
20.37
1.3
1.3
iu/ml
25.8
30.2
0.48
172
1316
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
141
605
2.40
20.13
1.9
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
320
1867
1.80
19.87
5.2
4.0
%
0.9
0.8
0.26
91
497
(3017143) Hepatitis C virus Ab [Presence] in Serum
461
2977
1.65
19.84
1.7
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
307
1778
1.81
19.52
5.3
4.1
%
0.1
0.1
0.07
82
461
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
920
6980
1.47
19.03
2.8
2.5
u/l
54.8
56.4
0.74
865
6470
(3035350) Ketones [Presence] in Urine by Test strip
1398
11484
1.42
18.70
4.3
3.5
estimate
0.0
0.0
0.50
319
2171
(46235355) HIV 1 and 2 tests - Meaningful Use set
741
5431
1.49
18.08
2.0
1.9
—
—
—
0
0
(3015736) pH of Urine
1122
8901
1.43
18.03
3.6
3.3
—
5.8
—
0
8
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
15
12.07
17.80
1.4
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
318
1911
1.75
17.78
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
97
371
2.67
17.63
1.7
1.4
—
—
—
0
0
(3010421) pH of Blood
130
572
2.33
17.56
6.3
4.0
ph
7.4
7.4
1.20
117
465
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1834
15904
1.42
17.52
3.5
3.0
u/l
48.3
42.9
2.06
1730
14969
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
55
152
3.67
17.31
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
134
606
2.27
16.98
1.3
1.2
titre
95.0
82.0
—
6
50
(3037756) Immunofixation for Serum or Plasma
101
402
2.57
16.96
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1399
11619
1.40
16.90
4.4
3.5
estimate
0.0
0.0
1.32
327
2150
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
111
470
2.42
16.36
1.3
1.2
u/ml
268.7
260.4
0.07
78
287
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
75
261
2.92
16.30
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1381
11495
1.39
16.20
6.0
4.7
estimate
0.0
0.0
0.50
338
2205
(40768804) Tissue Pathology biopsy report
1171
9485
1.40
16.17
2.2
2.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
36
76
4.78
16.12
1.2
1.2
—
—
—
0
0
(44806071)
24
34
7.11
16.10
1.4
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2377
21785
1.53
15.96
5.6
4.8
mu/l
1.8
2.1
1.46
2237
20247
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
287
1746
1.72
15.29
5.4
3.4
mmol/l
1.2
1.2
2.30
261
1503
(3051651) Icteric interference index of Serum or Plasma
48
132
3.68
15.25
4.0
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
670
4955
1.46
15.22
1.8
1.5
nmol/l
19.6
20.6
0.94
586
4282
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
77
283
2.77
15.16
2.6
2.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
267
1596
1.74
15.15
5.5
3.3
kpa
4.8
4.7
0.49
251
1540
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
113
500
2.31
15.10
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
548
3909
1.50
14.91
2.0
1.7
nmol/l
1106.4
1172.2
0.88
431
2981
(40760892) CBC W Ordered Manual Differential panel - Blood
722
5439
1.44
14.81
6.1
4.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
102
438
2.38
14.60
6.8
3.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
102
439
2.37
14.53
6.7
5.3
iu/ml
2437.4
387.2
—
7
56
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2077
18659
1.41
14.49
4.8
4.1
pmol/l
14.6
14.6
0.16
1948
17204
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
79
4.47
14.48
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
561
4047
1.48
14.38
1.3
1.3
u/ml
19.2
11.3
0.39
177
1658
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
266
1618
1.71
14.16
3.2
3.3
pmol/l
4.3
4.5
2.76
237
1445
(3048929) Epstein Barr virus Ab [Presence] in Serum
160
832
1.98
14.14
1.3
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
33
73
4.56
13.99
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
123
584
2.16
13.88
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
319
2051
1.62
13.72
5.3
3.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
126
609
2.12
13.59
1.9
2.1
mg/l
11.8
11.1
0.42
117
569
(3051611) Lipemic interference index of Serum or Plasma
60
207
2.94
13.30
4.1
3.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
754
5822
1.40
13.21
1.7
1.6
mmol/l
1.4
1.4
1.17
656
4955
(3002256) Pathology report gross observation
422
2921
1.52
13.13
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
113
532
2.17
13.04
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
51
162
3.19
13.02
1.2
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
34
82
4.18
12.96
7.7
3.9
mg/l
297.6
75.0
0.49
29
62
(40768797) Stomach Pathology biopsy report
442
3102
1.50
12.86
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
100
451
2.26
12.82
1.6
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
388
2658
1.53
12.65
1.7
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
62
227
2.77
12.35
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
438
3096
1.49
12.27
2.2
2.4
ug/g
136.3
115.5
0.56
344
2455
(3024891) Influenza virus A+B Ag [Presence] in Specimen
134
694
1.98
12.01
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2620
24844
1.62
11.94
14.8
9.5
u/l
26.5
25.4
1.82
2556
24051
(3024980) IgG subclass 4 [Mass/volume] in Serum
86
376
2.33
11.88
1.8
1.6
g/l
0.6
0.8
0.71
69
280
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
730
5692
1.38
11.85
1.4
1.3
u/ml
0.7
1.5
4.94
187
1555
(3011397) Hemoglobin [Presence] in Urine by Test strip
687
5304
1.39
11.85
3.9
3.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
256
1622
1.63
11.64
1.4
1.3
u/ml
115.7
213.7
2.93
241
1499
(3022145) Colonoscopy Study observation
351
2397
1.53
11.57
1.4
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
171
971
1.81
11.56
2.1
2.0
u/l
38.8
39.0
0.03
149
880
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
84
370
2.31
11.42
1.6
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
98
461
2.17
11.37
2.9
2.2
g/l
130.8
131.1
0.04
76
352
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
73
4.14
11.32
1.9
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
71
293
2.46
11.16
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2368
22059
1.42
11.15
26.4
13.7
%
39.4
39.7
1.21
1872
16697
(1616796) Gas panel - Central venous blood
97
459
2.15
11.10
6.0
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
163
934
1.79
10.71
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
60
234
2.60
10.62
12.7
6.7
mmol/l
6.7
7.3
0.87
53
198
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
105
525
2.04
10.42
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
206
1271
1.67
10.39
1.7
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
27
66
4.12
10.15
4.7
5.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2594
24699
1.52
9.80
20.6
12.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
54
210
2.60
9.64
1.3
1.2
u/l
44.1
64.7
1.59
41
147
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
101
516
1.99
9.47
1.6
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
249
1647
1.56
9.45
2.3
2.4
au/ml
25.9
22.2
—
8
114
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
9
0
+∞
9.38
2.4
0.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
17
30
5.69
9.27
1.8
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
16
27
5.95
9.12
12.9
10.1
mmol/l
6.4
6.3
0.03
16
27
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
47
176
2.70
9.06
4.0
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
32
96
3.36
9.03
27.1
27.1
ug/l
109.1
115.2
0.19
27
82
(3013293) Extractable nuclear Ab [Presence] in Serum
17
31
5.51
8.97
1.5
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
39
133
2.96
8.92
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
128
723
1.81
8.87
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
115
630
1.86
8.79
2.4
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
62
270
2.32
8.73
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
204
1315
1.59
8.66
6.4
5.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
80
390
2.08
8.56
1.5
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
46
176
2.64
8.52
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
217
1426
1.56
8.48
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
799
6581
1.30
8.44
3.8
3.2
mmol/l
7.1
7.6
2.38
686
5591
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
38
132
2.90
8.43
1.7
1.4
u/l
5.1
6.2
0.78
31
109
(3006922) Hepatitis E virus Ab [Presence] in Serum
40
143
2.82
8.43
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
320
2284
1.45
8.41
1.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2210
20620
1.31
8.32
5.8
5.2
mmol/mol
39.0
39.1
0.36
2053
19227
(42529406) Shigella sp [Presence] in Stool by Culture
127
731
1.77
8.28
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
42
156
2.72
8.25
2.4
2.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
49
197
2.51
8.23
2.0
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
29
87
3.36
8.20
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
125
720
1.77
8.14
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
38
135
2.84
8.11
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
78
385
2.05
8.09
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
246
1680
1.51
8.07
2.2
2.3
ug/l
9.6
6.9
0.87
211
1478
(3021901) Oxygen saturation in Capillary blood
74
359
2.09
8.04
4.0
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
198
1300
1.56
7.79
5.6
3.7
mmol/l
1.7
1.7
0.04
145
956
(3000012) Reticulocyte production index
30
96
3.15
7.68
1.6
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
103
3.03
7.46
1.8
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
103
3.03
7.46
1.8
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
238
2.29
7.45
1.5
1.4
g/l
2.6
2.9
0.59
40
163
(3024139) IgG subclass 3 [Mass/volume] in Serum
54
238
2.29
7.45
1.5
1.4
g/l
0.3
0.4
1.94
42
162
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1835
16823
1.25
7.43
3.9
3.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
54
239
2.28
7.38
1.5
1.4
g/l
6.5
6.7
0.19
42
164
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
12
9
13.38
7.38
1.3
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
77
392
1.99
7.37
1.7
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
125
743
1.71
7.32
1.5
1.6
iu/ml
0.1
8.9
0.50
24
137
(3009343) pH of Capillary blood
201
1345
1.53
7.27
5.6
3.7
ph
7.4
7.4
0.72
42
154
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
119
703
1.72
7.13
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
137
841
1.66
7.12
1.9
1.7
—
—
—
0
0
(4062490)
54
243
2.25
7.11
1.6
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
44
182
2.44
7.01
1.4
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
20
52
3.87
6.98
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
52
3.87
6.98
3.0
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
201
1359
1.52
6.94
5.6
3.7
kpa
5.2
5.2
0.02
185
1272
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
154
984
1.60
6.83
1.8
1.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
50
222
2.27
6.81
1.5
1.4
g/l
31.8
33.1
0.27
39
197
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
28
5.02
6.70
2.2
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
73
378
1.96
6.69
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
32
4.71
6.68
5.1
6.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
764
6415
1.26
6.65
4.2
3.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
47
207
2.29
6.54
2.5
2.4
e9/l
1.1
1.2
0.38
31
123
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
64
319
2.03
6.54
1.9
1.2
u/l
25.5
35.3
0.54
58
273
(4035726)
255
1834
1.43
6.44
1.5
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
704
5879
1.26
6.38
3.8
3.3
mg/l
558.4
353.1
0.45
479
3743
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
275
2008
1.41
6.38
3.4
4.0
ug/l
4.1
37.3
1.27
202
1590
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
42
178
2.38
6.38
1.1
1.2
u/ml
54.6
54.2
—
5
17
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
155
2.47
6.27
1.5
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
156
2.46
6.19
1.8
2.5
e6/l
627.5
770.8
0.53
11
63
(3034274) Bile acid [Moles/volume] in Serum --fasting
78
425
1.86
6.17
2.8
2.4
umol/l
5.4
6.0
0.32
58
313
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
206
1437
1.47
6.12
2.6
2.2
u/l
3670.8
5257.5
0.56
88
569
(3000570) Elastase.pancreatic [Mass/mass] in Stool
105
627
1.70
6.10
1.5
1.4
ug/g
304.7
296.5
0.14
59
346
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
630
5220
1.26
6.07
1.8
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
183
1252
1.49
6.00
1.1
1.1
titre
—
98.1
—
0
27
(3004616) Nuclear Ab [Presence] in Serum
56
276
2.05
5.93
1.3
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
9
6
15.04
5.90
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
113
696
1.65
5.86
3.3
3.4
u/ml
560.4
5871.5
0.73
92
593
(1002224) Polysomnography panel
154
1022
1.54
5.84
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
30
113
2.67
5.82
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
53
258
2.07
5.80
3.2
2.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
38
162
2.36
5.73
2.1
2.1
%
10.9
12.5
0.42
18
90
(3023183) Ammonium ion [Moles/volume] in Plasma
78
436
1.81
5.71
5.1
2.7
umol/l
34.6
34.2
0.06
67
370
(3020682) Albumin/Creatinine [Ratio] in Urine
730
6188
1.24
5.71
4.9
4.0
mg/mmol
12.6
9.6
0.86
489
3956
(3042111) Morphology [Interpretation] in Bone marrow Narrative
62
324
1.93
5.59
1.7
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
38
164
2.33
5.58
2.2
2.2
%
72.7
72.2
0.06
38
158
(3035637) Corticotropin [Mass/volume] in Plasma
57
290
1.99
5.55
1.8
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
811
6972
1.23
5.53
1.7
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
139
913
1.55
5.53
5.7
2.8
%
0.6
0.7
2.11
134
885
(4010399)
216
1551
1.42
5.53
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
72
397
1.83
5.52
4.3
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
375
2941
1.32
5.51
1.7
1.8
%
1.5
1.4
0.29
326
2608
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
376
1.86
5.49
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
22
72
3.07
5.49
2.0
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
109
677
1.63
5.49
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
17
47
3.63
5.48
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
17
47
3.63
5.48
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
17
47
3.63
5.48
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
17
47
3.63
5.48
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
21
67
3.15
5.46
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
120
767
1.59
5.38
3.3
3.4
g/l
0.3
0.3
0.15
67
312
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
333
1.88
5.18
1.4
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
268
2019
1.36
5.17
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
39
177
2.22
5.13
2.3
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
30
121
2.49
5.12
1.8
2.7
u/ml
663.8
1125.6
1.07
30
121
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
134
2.40
5.05
1.8
1.6
u/l
4.5
6.7
0.56
22
69
(3029937) Albumin [Presence] in Urine by Test strip
721
6174
1.22
5.04
5.0
3.8
estimate
0.0
0.0
1.49
334
2158
(40757373) Influenza virus identified in Isolate
16
45
3.57
5.04
1.8
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
45
219
2.07
4.98
1.3
1.3
—
—
—
0
0
(4027681)
38
173
2.21
4.97
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
187
2.16
4.91
1.5
1.3
e6/l
182011.9
66730.4
0.30
27
105
(3044290) Cell count panel - Cerebral spinal fluid
82
488
1.70
4.89
1.6
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
66
370
1.80
4.84
2.6
3.2
nmol/l
0.8
0.8
0.23
51
293
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
54
284
1.92
4.83
2.7
2.5
u/ml
5.0
20.3
0.54
49
260
(3024932) HLA-DR beta [Type]
20
67
3.00
4.82
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
25
95
2.65
4.81
1.8
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2282
21778
1.23
4.81
4.2
3.6
mmol/l
1.3
1.3
1.56
2117
20166
(44790047)
51
264
1.95
4.78
1.6
1.5
—
—
—
0
0
(44806118)
51
264
1.95
4.78
1.6
1.5
—
—
—
0
0
(44790049)
51
264
1.95
4.78
1.6
1.5
—
—
—
0
0
(44790048)
51
264
1.95
4.78
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
93
576
1.64
4.78
1.3
1.4
—
—
—
0
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
10
20
5.01
4.77
1.5
1.5
mg/l
0.8
0.6
—
5
13
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
10
20
5.01
4.77
1.5
1.5
mg/l
5.6
3.6
—
5
11
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
10
20
5.01
4.77
1.5
1.5
mg/l
1.5
1.6
—
5
12
(3015235) Bicarbonate [Moles/volume] in Capillary blood
85
515
1.67
4.76
4.8
3.0
mmol/l
24.9
24.8
0.09
78
451
(3045414) Leukocytes [Presence] in Urine
147
1011
1.48
4.76
1.8
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
57
307
1.87
4.75
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2372
22740
1.25
4.74
4.7
4.0
mmol/l
4.5
4.7
14.08
2221
21276
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
90
2.68
4.74
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
40
190
2.12
4.73
3.1
3.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
43
211
2.05
4.68
1.5
1.4
e6/l
7480.6
1970.3
0.41
33
146
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2404
23092
1.25
4.66
5.2
4.4
mmol/l
2.7
2.8
11.91
2236
21463
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
288
1.89
4.65
1.8
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
15
43
3.50
4.61
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
20
69
2.91
4.60
2.8
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
192
1400
1.40
4.54
1.3
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
176
1264
1.42
4.54
11.3
7.2
mmol/l
24.9
24.4
1.03
164
1179
(40768806) Pleura Pathology biopsy report
38
181
2.11
4.48
1.6
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
49
3.28
4.46
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
43
215
2.02
4.46
1.1
1.2
mg/l
43.4
37.9
0.41
36
177
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
26
105
2.49
4.46
1.1
1.1
iu/ml
162.4
171.6
0.08
26
105
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
239
1813
1.35
4.43
1.6
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
86
534
1.63
4.40
1.6
1.5
e6/l
25.5
30.4
0.11
69
423
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
86
534
1.63
4.40
1.6
1.6
e6/l
544.6
1303.8
0.69
72
443
(21494434) Karyotype in Bone marrow
36
169
2.14
4.40
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
142
986
1.46
4.40
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
47
244
1.94
4.40
2.7
2.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
60
338
1.79
4.37
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
36
170
2.13
4.34
1.6
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
35
164
2.15
4.31
2.4
3.2
%
9.7
11.2
1.15
35
164
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
61
347
1.77
4.30
1.6
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
53
289
1.85
4.29
1.2
1.1
g/l
1.5
1.5
0.06
53
263
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
66
386
1.73
4.24
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
41
206
2.00
4.22
1.0
1.1
mg/l
219.0
234.4
0.27
33
176
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2352
22597
1.22
4.20
4.7
4.0
mmol/l
1.4
1.5
9.60
2181
21022
(3009871) Measles virus Ab [Titer] in Serum
20
73
2.75
4.18
1.6
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
60
344
1.76
4.14
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
117
793
1.50
4.11
1.4
1.4
u/l
11.5
10.4
0.29
89
643
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
29
129
2.26
4.06
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
169
1233
1.39
4.02
5.7
3.2
g/l
125.7
128.9
1.03
164
1201
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
115
781
1.49
4.01
2.7
1.9
ug/l
1.7
2.1
0.22
99
685
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
156
2.13
3.99
1.1
1.1
u/l
1.0
1.1
0.40
14
73
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
247
1914
1.32
3.98
1.3
1.2
iu/ml
176.3
154.0
0.28
86
734
(3036071) Salmonella sp Ab [Titer] in Serum
24
99
2.44
3.97
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
107
720
1.50
3.91
2.4
2.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2151
20534
1.19
3.90
29.8
16.2
g/l
331.3
332.4
6.56
2135
20367
(3016018) Differential panel - Cerebral spinal fluid
45
242
1.87
3.83
1.6
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
44
235
1.89
3.83
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
80
508
1.59
3.79
1.6
1.8
e6/l
14420.3
14083.7
0.02
50
375
(3017817) Protein [Mass] in Urine collected for unspecified duration
38
194
1.97
3.77
2.5
2.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
8
8.77
3.77
2.3
3.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
8
8.77
3.77
2.1
3.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2693
26347
1.35
3.76
34.5
18.8
e9/l
249.8
257.0
6.04
2651
25725
(3019832) Treponema pallidum Ab [Presence] in Serum
390
3224
1.24
3.75
1.7
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
46
252
1.84
3.71
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
35
175
2.01
3.69
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
62
372
1.68
3.68
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
56
327
1.73
3.66
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
103
2.34
3.66
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
146
1057
1.40
3.66
1.5
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
16
5.64
3.65
1.1
1.4
—
—
—
0
0
(3013512) EKG study
686
6010
1.19
3.63
4.1
3.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
162
1196
1.38
3.62
1.5
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
2693
26362
1.34
3.61
34.3
18.8
fl
90.7
90.6
0.57
2671
26018
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
98
660
1.50
3.59
1.6
1.9
iu/l
2.4
4.4
5.82
34
256
(3035941) MCH [Entitic mass]
2693
26364
1.34
3.59
34.3
18.7
pg
30.1
30.2
1.48
2671
26016
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
356
2929
1.25
3.57
2.0
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2693
26366
1.34
3.57
34.4
18.8
e12/l
4.4
4.5
5.01
2648
25684
(3010813) Leukocytes [#/volume] in Blood
2693
26371
1.34
3.52
34.5
18.9
e9/l
6.9
6.8
1.91
2647
25681
(21494755) Public health laboratory ask at order entry panel
205
2634
0.76
3.50
1.3
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
41
3.18
3.49
1.3
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
31
3.56
3.48
1.2
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2693
26376
1.33
3.47
34.7
18.9
g/l
132.5
134.6
12.26
2674
26025
(3023410) Appearance of Cerebral spinal fluid
45
251
1.81
3.45
1.6
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
47
266
1.78
3.44
1.2
1.3
nmol/l
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
47
268
1.77
3.36
1.6
1.5
mu/l
41.3
78.9
0.50
41
238
(3036525) Urea [Moles/time] in 24 hour Urine
7
10
7.01
3.36
3.0
3.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
148
1091
1.38
3.36
2.5
2.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
101
2.29
3.36
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
986
8939
1.16
3.35
4.6
3.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
161
2.00
3.34
1.9
2.4
e6/l
471.3
543.9
0.35
23
136
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
190
1.91
3.29
1.3
1.5
%
29.0
34.2
0.33
21
115
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
115
2.18
3.28
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
206
1605
1.31
3.24
1.4
1.4
iu/l
23.1
25.6
0.62
172
1367
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2297
22155
1.18
3.23
4.6
4.1
mmol/l
5.8
5.8
0.33
2101
20371
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
60
2.68
3.22
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
57
348
1.65
3.21
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
22
97
2.28
3.19
1.1
1.5
%
6.4
4.8
—
8
18
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
40
222
1.81
3.15
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
36
194
1.87
3.11
1.3
1.2
u/ml
2.9
0.6
0.43
18
79
(40768446) Kidney Pathology biopsy report
19
80
2.38
3.06
1.9
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
133
980
1.37
3.05
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
133
981
1.37
3.04
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
78
521
1.51
3.03
2.1
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
37
204
1.82
2.99
1.0
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
5
10.01
2.98
1.4
3.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
71
468
1.53
2.94
1.2
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
36
198
1.83
2.93
1.5
1.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
8
17
4.72
2.92
1.9
2.3
ug/g
157.6
200.9
—
8
17
(3017704) Immunofixation for Urine
23
108
2.14
2.90
1.6
1.7
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
9
22
4.10
2.88
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
9
22
4.10
2.88
1.3
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
13
5.39
2.87
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
237
1.74
2.85
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
74
496
1.50
2.84
1.7
1.4
nmol/l
0.6
0.5
0.26
60
396
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
109
2.12
2.84
1.7
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
109
2.12
2.84
1.7
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
131
978
1.36
2.80
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
151
1153
1.33
2.78
1.4
1.6
mu/l
282.4
307.7
0.52
136
1032
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
78
532
1.48
2.77
1.2
1.4
mmol/l
3.6
3.7
0.29
71
502
(3045424) Erythrocytes [Presence] in Urine
58
371
1.57
2.75
1.5
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
131
981
1.35
2.75
1.5
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
86
599
1.45
2.74
1.4
1.4
mg/l
472.9
488.7
0.15
80
569
(3003181) Sodium [Moles/volume] in Urine
55
349
1.59
2.71
1.5
1.4
mmol/l
68.5
64.5
0.23
42
283
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
19
4.22
2.67
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
144
1099
1.33
2.67
4.1
2.7
e6/l
0.1
0.3
7.57
139
1058
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
70
471
1.50
2.66
1.7
1.3
ug/l
3.1
4.1
0.59
65
434
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
42
250
1.69
2.65
1.4
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
102
739
1.39
2.63
1.1
1.1
u/ml
2.2
3.8
0.57
14
104
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
67
2.40
2.63
1.8
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
132
998
1.34
2.61
6.4
3.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
110
809
1.37
2.60
1.5
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
15
4.68
2.59
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
177
1396
1.29
2.59
2.3
3.0
u/ml
30.1
45.5
1.36
169
1348
(3020891) Body temperature
107
786
1.38
2.55
8.1
4.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
11
5.46
2.54
2.8
3.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
51
324
1.58
2.52
3.8
3.1
%
1.0
1.5
0.78
42
258
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
158
1.84
2.48
2.0
2.4
e9/l
0.2
0.2
0.08
23
136
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
16
4.38
2.47
1.1
1.4
u/l
4.3
9.9
—
7
16
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
117
877
1.35
2.47
6.4
4.0
mmol/l
24.6
24.7
0.19
108
817
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
27
3.34
2.39
1.2
2.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
91
660
1.39
2.37
5.3
7.0
mmol/l
1.3
1.3
0.17
81
572
(3005033) Fetal Nuchal fold Thickness US
108
806
1.35
2.36
1.5
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
200
1.71
2.28
2.5
2.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
53
2.46
2.27
1.1
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
13
4.62
2.27
1.0
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
29
163
1.79
2.27
1.6
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
23
120
1.92
2.25
1.0
1.1
miu/ml
1959.2
1468.7
1.54
23
120
(3009466) Valproate [Moles/volume] in Serum or Plasma
50
326
1.54
2.24
4.1
5.4
umol/l
364.1
367.9
0.06
45
283
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
255
1.62
2.24
1.3
1.7
%
54.4
60.1
0.39
27
163
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
86
2.10
2.22
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
36
217
1.67
2.22
1.8
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
93
2.05
2.21
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
225
1.65
2.21
1.5
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
44
280
1.58
2.20
1.6
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
187
1518
1.25
2.20
3.0
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
110
834
1.33
2.19
1.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
33
195
1.70
2.19
2.0
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
24
3.34
2.18
1.4
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
59
403
1.47
2.15
1.1
1.0
u/ml
1.3
2.1
0.71
18
193
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
38
235
1.63
2.13
1.3
1.4
mmol/l
13.6
12.3
0.24
14
46
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
82
2.08
2.06
4.2
4.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
30
176
1.71
2.06
1.5
1.3
mmol/l
1.9
1.9
0.04
25
166
(3035880) pH of Pleural fluid
20
103
1.95
2.05
1.4
1.3
—
—
—
0
0
(3025315) Body weight
6
15
4.01
2.04
6.2
3.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
55
375
1.48
2.03
1.3
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
125
1.85
2.02
1.7
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
113
872
1.31
2.01
1.5
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
26
3.08
2.01
1.1
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
119
925
1.30
2.01
1.7
1.6
—
—
—
0
0
(44813793)
30
178
1.69
1.98
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
22
119
1.86
1.97
1.6
1.3
titre
100.0
71.3
—
5
15
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
265
1.56
1.95
1.2
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
51
2.36
1.95
8.1
6.7
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
8
27
2.97
1.93
1.8
4.1
—
13.2
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
27
2.97
1.93
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
16
3.76
1.93
1.2
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
6
16
3.76
1.93
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
16
3.76
1.93
1.2
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
273
2335
1.19
1.93
1.9
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
142
1.77
1.92
2.0
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.92
2.7
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
135
1.78
1.91
1.6
2.9
%
43.3
40.3
—
6
45
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
17
85
2.01
1.90
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
267
1.54
1.89
1.2
1.4
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
7
22
3.19
1.88
5.4
3.6
mg/l
2.2
2.8
—
7
16
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
22
3.19
1.88
1.3
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
65
466
1.40
1.87
3.8
2.1
nmol/l
1.0
0.8
0.71
56
388
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
190
1.64
1.84
1.1
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
58
409
1.43
1.83
1.9
1.8
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
12
4.17
1.82
11.4
3.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
73
2.06
1.80
2.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
18
94
1.92
1.80
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
16
80
2.01
1.79
1.6
2.0
e6/l
140.0
218.8
—
10
43
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
11
47
2.35
1.77
1.1
1.7
nmol/l
0.2
0.2
—
5
32
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
47
2.35
1.77
8.4
6.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
40
264
1.52
1.76
1.2
1.5
—
—
—
0
0
(4212803)
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
31
194
1.60
1.71
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
31
194
1.60
1.71
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
31
194
1.60
1.71
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
40
266
1.51
1.71
1.2
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
351
3100
1.15
1.68
2.9
3.0
ug/l
0.7
0.8
0.13
233
2011
(40765096) Chromosome analysis panel by Banding
12
55
2.19
1.67
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
65
477
1.37
1.66
2.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
40
268
1.50
1.66
1.2
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
25
2.80
1.65
1.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
27
165
1.64
1.64
1.0
1.1
iu/ml
9.8
10.4
—
7
42
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
270
1.49
1.61
1.2
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
32
2.50
1.59
1.1
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
15
77
1.95
1.59
3.7
2.9
umol/l
24.4
29.0
—
10
59
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
19
106
1.80
1.58
1.2
1.1
u/l
65.2
26.6
0.30
12
79
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
28
175
1.61
1.57
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
160
1.63
1.55
1.3
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
19
107
1.78
1.54
1.2
1.1
u/l
118.9
84.3
0.36
14
85
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
15
3.34
1.52
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
194
1652
1.19
1.49
2.9
2.7
e9/l
4.5
4.1
0.99
149
1343
(3008295) Osmolality of Serum or Plasma
35
235
1.50
1.46
1.4
1.6
mosm/kgh2o
289.7
280.9
1.72
24
178
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
28
2.50
1.45
1.1
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
18
102
1.77
1.44
1.8
2.3
%
13.7
10.7
0.23
18
95
(3028679) Herpes simplex virus Ab [Presence] in Serum
24
148
1.63
1.44
1.1
1.2
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
16
3.13
1.44
1.2
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
19
110
1.73
1.42
2.3
2.2
umol/l
37.3
48.7
1.28
13
87
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
64
483
1.33
1.41
1.7
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
118
964
1.23
1.40
1.3
1.3
miu/ml
245.6
218.3
0.33
49
483
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
181
1.55
1.40
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
111
1.72
1.39
2.1
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
60
2.00
1.38
1.8
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
73
564
1.30
1.37
1.3
1.2
—
—
—
0
0
(4034850)
56
745
0.75
1.37
13.1
8.9
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
23
2.61
1.36
1.2
1.0
u/ml
0.7
0.2
—
6
13
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
422
3830
1.12
1.35
2.2
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
112
916
1.23
1.33
2.3
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
228
2605
0.86
1.33
4.3
4.1
%
31.7
32.4
0.38
170
1824
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
128
1.65
1.33
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
54
2.04
1.32
1.9
1.9
—
—
—
0
0
(4281824)
35
241
1.46
1.32
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
76
1.85
1.29
1.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
76
1.85
1.29
1.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
34
234
1.46
1.29
1.5
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
128
1066
1.21
1.29
3.0
3.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
114
1.67
1.28
1.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
114
1.67
1.28
1.6
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
114
1.67
1.28
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
114
1.67
1.28
1.6
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
159
1354
1.18
1.26
2.3
2.1
nmol/l
11.0
11.6
0.44
135
1190
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
162
1382
1.18
1.26
1.1
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
14
77
1.82
1.25
10.9
12.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
376
3407
1.12
1.25
2.0
2.0
—
—
—
0
0
(4211845)
19
115
1.66
1.24
2.3
2.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
25
2.40
1.24
1.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
34
237
1.44
1.22
3.9
3.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
93
1.72
1.21
2.4
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
178
1539
1.17
1.19
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
38
2.11
1.18
2.1
1.9
—
—
—
0
0
(3039000) Anion gap in Blood
59
454
1.31
1.18
6.2
8.5
mmol/l
11.8
11.4
0.33
52
406
(3023511) Choriogonadotropin [Units/volume] in Urine
94
767
1.23
1.17
1.4
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
157
1.53
1.17
1.2
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
59
455
1.30
1.16
6.2
8.5
mmol/l
103.9
105.3
1.54
52
407
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
27
182
1.49
1.15
1.6
1.5
g/l
0.9
0.9
0.38
27
182
(3008536) Aspergillus sp Ab [Presence] in Serum
8
39
2.05
1.15
2.5
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
166
1.51
1.15
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
167
1.50
1.12
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
49
371
1.33
1.11
1.3
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
31
218
1.43
1.09
1.6
2.2
nmol/l
18.8
19.8
0.23
31
209
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
324
2937
1.12
1.09
1.5
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
105
1.62
1.06
2.4
2.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
33
2.12
1.05
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
35
254
1.38
1.04
3.1
2.3
mg/l
46.8
25.6
—
8
71
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
22
2.27
1.03
2.6
1.7
umol/l
50.6
45.2
—
5
22
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
49
376
1.31
1.03
2.9
3.6
u/ml
46.7
1076.8
0.89
41
350
(3052592) Norovirus Ag [Presence] in Stool
7
34
2.06
1.03
1.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
538
5017
1.09
1.02
4.5
3.8
kg/l
1.0
1.0
0.44
80
746
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
47
1.92
1.02
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
53
1.89
1.01
2.0
2.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
23
2.18
0.98
3.4
2.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
84
1.67
0.97
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
50
1.80
0.96
1.6
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.4
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
51
1.77
0.94
1.7
1.3
%
17.7
30.4
—
9
45
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
93
1.62
0.93
1.1
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
27
2.22
0.93
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
150
1.47
0.92
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
820
8605
0.93
0.92
2.7
2.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
78
1.67
0.91
1.5
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
94
1.60
0.90
2.8
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
569
5350
1.08
0.90
4.3
4.8
ug/l
3.2
3.9
0.27
503
4795
(3028433) Virus identified in Specimen by Culture
13
79
1.65
0.88
1.2
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
32
237
1.35
0.87
2.9
4.9
u/ml
242.9
82.6
0.30
11
72
(3042517) Benzodiazepines panel - Urine
6
30
2.00
0.87
1.7
2.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
25
178
1.41
0.86
1.3
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
72
1.67
0.85
1.4
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
25
0.00
0.79
0.0
1.5
—
9.4
—
0
10
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
66
1.67
0.78
3.1
2.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
13
82
1.59
0.78
3.6
3.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
51
413
1.24
0.75
1.1
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
25
2.00
0.72
2.2
1.3
ng/l
208.8
95.9
—
5
25
(3011288) Drugs identified in Urine by Screen method
93
802
1.16
0.72
3.5
2.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
64
534
1.20
0.72
2.0
1.7
nmol/l
40.7
40.9
0.02
64
516
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
95
821
1.16
0.72
2.2
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
56
1.61
0.72
2.2
1.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
76
1.58
0.71
1.3
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
16
109
1.47
0.71
1.7
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
126
1.43
0.70
1.7
1.4
nmol/l
135.9
136.1
0.00
18
126
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
48
391
1.23
0.69
3.4
3.7
u/ml
27.2
28.4
0.04
48
380
(40761535) Cells panel - Urine sediment
194
1766
1.11
0.67
3.8
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
94
1.49
0.66
1.4
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
94
1.49
0.66
1.4
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
94
1.49
0.66
1.9
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
496
4700
1.07
0.65
1.8
1.6
pmol/l
444.3
31092440.1
3.95
403
3956
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
21
154
1.37
0.65
1.0
1.1
nmol/l
0.2
8.6
—
6
25
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
200
1828
1.10
0.64
1.9
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
95
1.48
0.64
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
95
1.48
0.64
1.6
1.9
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.6
2.1
mg/l
1.8
1.3
—
5
24
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
29
1.73
0.64
16.8
6.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
35
436
0.80
0.62
1.1
1.1
u/ml
0.5
4.5
3.90
14
162
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
79
1.52
0.62
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
93
815
1.15
0.61
5.0
5.9
%
2.0
1.6
1.48
83
761
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
30
1.67
0.61
2.6
3.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
41
500
0.82
0.61
3.0
2.5
ug/min
102.0
94.4
0.05
22
311
(3019225) pH of Specimen
226
2087
1.09
0.60
4.9
3.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
417
1.20
0.60
1.3
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
15
105
1.43
0.60
2.2
1.8
mmol/l
8.7
9.7
—
10
82
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
52
1.54
0.59
1.9
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
76
659
1.16
0.59
1.5
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
13
89
1.46
0.58
1.1
1.1
ng/l
32.6
290.1
—
5
19
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
149
1.34
0.57
1.4
1.2
—
—
—
0
0
(4094501)
65
558
1.17
0.57
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
99
878
1.13
0.56
2.3
2.1
—
—
—
0
0
(4015189)
8
55
1.46
0.56
1.5
2.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
363
0.80
0.56
1.1
1.1
u/ml
0.1
0.3
—
9
90
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
216
2331
0.92
0.55
1.6
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
15
107
1.40
0.55
1.7
3.1
ph
7.5
7.4
—
5
33
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
21
159
1.32
0.55
1.9
2.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
460
1.18
0.53
1.2
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
1.0
1.2
nmol/l
2.3
5.1
—
6
40
(3023487) Leukocytes [#/volume] in Peritoneal fluid
11
75
1.47
0.50
2.0
2.3
e6/l
682.6
863.4
—
5
61
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
46
1.52
0.48
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
53
457
1.16
0.47
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
120
1.34
0.46
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
120
0.67
0.45
1.6
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
90
808
1.12
0.45
5.2
5.9
%
0.9
0.9
0.12
82
755
(1617658) Protocol used for examination of sentinel lymph nodes
24
193
1.25
0.43
1.1
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
92
1017
0.90
0.42
1.5
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
45
521
0.86
0.42
3.5
4.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
239
2535
0.94
0.42
8.6
6.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
105
1.33
0.41
2.1
3.0
umol/l
43.9
170.2
—
7
64
(40768800) Prostate Pathology biopsy report
26
315
0.82
0.40
1.2
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
17.3
—
0
17
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
53
464
1.14
0.40
1.6
1.4
u/l
18.2
23.8
0.72
46
394
(3020874) Milk IgE Ab [Units/volume] in Serum
22
177
1.24
0.40
1.1
1.1
u/ml
17.6
2.4
0.41
13
67
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
171
0.76
0.39
1.1
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
35
1.43
0.39
1.4
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
22
178
1.24
0.38
1.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
36
1.39
0.38
2.4
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
36
1.39
0.38
1.2
3.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
12
89
1.35
0.38
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
122
1127
1.09
0.37
2.3
2.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
170
1.24
0.37
1.5
2.2
u/field
2.9
2.0
0.24
14
72
(3000764) Benzodiazepines [Presence] in Urine
121
1119
1.08
0.36
2.4
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
122
1130
1.08
0.36
2.4
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
43
1.40
0.35
1.2
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
44
1.36
0.34
1.7
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
60
538
1.12
0.34
1.2
1.1
u/ml
4.8
5.6
0.18
40
289
(40768795) Lymph node Pathology biopsy report
24
201
1.20
0.32
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
84
770
1.09
0.32
2.0
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
65
590
1.10
0.30
1.2
1.2
u/ml
1.0
1.4
0.27
30
243
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
153
0.78
0.30
1.4
1.4
mmol/l
5.4
5.7
0.40
12
148
(3027944) Amphetamines [Presence] in Urine
119
1111
1.07
0.30
2.4
2.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
22
185
1.19
0.29
1.1
1.1
u/ml
0.2
1.0
—
10
55
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
103
1.26
0.28
2.5
1.6
iu/ml
—
1277786.7
—
0
9
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
76
1.32
0.28
1.3
1.4
ug/l
10.4
8.9
—
10
76
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
65
1.23
0.27
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
65
1.23
0.27
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
66
1.21
0.26
1.8
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
95
1.26
0.26
1.2
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
273
1.14
0.25
1.5
1.5
mmol/l
7.9
7.7
0.13
17
163
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
158
0.82
0.23
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
492
4800
1.03
0.23
1.5
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
43
389
1.11
0.23
1.1
1.1
iu/ml
92.4
1371.4
0.50
14
98
(3028707) Methadone [Presence] in Urine by Screen method
56
515
1.09
0.22
3.1
2.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
110
1039
1.06
0.22
2.4
2.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
42
1.19
0.21
2.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
42
1.19
0.21
2.2
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
42
1.19
0.21
2.2
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
42
1.19
0.21
2.2
1.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017958) Strawberry IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
40
363
1.10
0.21
1.4
1.4
mmol/l
6.9
7.3
0.32
27
261
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(40758358) Immune stain study
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
102
964
1.06
0.21
5.3
3.2
mmol/l
25.5
25.2
0.42
97
931
(3016750) Collection duration of Urine
15
126
1.19
0.21
2.3
2.3
min
511.1
498.7
—
10
93
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
20.9
—
0
13
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
36.9
—
0
13
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
8.0
—
0
13
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
48.0
—
0
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
35
387
0.90
0.20
1.8
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
164
1.16
0.20
2.0
2.4
ml
1136.4
620.5
1.45
11
111
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
6
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
50
1.20
0.19
1.7
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
4.0
2.3
umol/l
15.4
16.5
—
6
51
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
154
1605
0.96
0.19
1.3
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
34
374
0.91
0.18
2.5
1.8
pmol/l
190.0
198.6
0.13
34
349
(4198724)
13
109
1.19
0.18
2.6
1.9
—
—
—
0
0
(4133840)
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
88
926
0.95
0.17
1.5
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
36
392
0.92
0.17
1.1
1.1
u/ml
1.0
5.0
4.18
18
153
(3015183) Erythrocyte sedimentation rate
17
148
1.15
0.17
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(4146454)
18
204
0.88
0.16
3.1
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
235
0.89
0.16
3.0
2.5
—
—
—
0
0
(4024509)
18
203
0.89
0.15
1.7
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
207
1.11
0.15
3.2
2.9
%
61.1
55.2
0.48
13
143
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
94
1.17
0.13
1.0
2.6
ug/l
1.7
1.1
0.22
11
86
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
1056
0.96
0.11
1.5
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
87
1.15
0.09
5.4
3.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
1.3
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.1
u/ml
28.4
40.7
—
6
57
(3020650) Glucose [Presence] in Urine
7
64
1.09
0.08
1.1
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
64
1.09
0.08
2.0
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
64
1.09
0.08
2.0
2.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
244
1.07
0.08
1.4
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
67
1.04
0.08
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
99
1015
0.97
0.07
1.5
1.7
mg/l
3.0
4.1
0.68
66
700
(3026470) Cobalt [Mass/volume] in Blood
12
108
1.11
0.07
1.8
2.0
ug/l
9.4
2.9
—
6
94
(3039443) Prostate specific Ag panel - Serum or Plasma
34
325
1.05
0.06
1.5
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
53
513
1.03
0.06
1.2
1.1
u/ml
0.8
1.0
0.14
30
223
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
119
1.09
0.06
2.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
154
1563
0.98
0.05
1.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
47
455
1.03
0.05
1.7
1.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
110
1.09
0.05
1.8
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
91
1.10
0.04
1.4
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
20
191
1.05
0.03
1.2
1.1
nmol/l
377.8
396.8
0.16
14
172
(3051387) C reactive protein [Mass/volume] in Capillary blood
47
481
0.98
0.03
6.7
3.5
mg/l
28.6
23.6
0.37
35
316
(3044242) Glucose [Moles/volume] in Arterial blood
12
112
1.07
0.03
2.1
2.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
51
501
1.02
0.02
1.1
1.1
u/ml
0.2
2.6
—
9
127
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
428
4287
1.00
0.00
3.7
4.2
%
24.0
21.7
1.86
172
2011
(40768793) Breast Pathology biopsy report
58
585
0.99
0.00
1.4
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
134
0.97
0.00
1.1
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
146
1.03
0.00
5.6
7.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
10
102
0.98
0.00
1.9
2.1
—
203.4
—
0
23
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
15
152
0.99
0.00
8.9
12.6
nmol/l
759.5
839.8
0.28
15
146
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
107
1.03
0.00
1.0
1.3
pmol/l
186.1
49.9
—
5
36
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
71
0.99
0.00
1.1
1.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
9
0.00
0.00
0.0
1.0
—
1026.0
—
0
9
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
63
0.95
0.00
3.3
1.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
1.0
1.1
ug/l
42.6
76.8
—
5
44
Mortality – FinRegistry
↥Association
Association between endpoint D3_COAGOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGOTHER | 1.969 [1.68, 2.3] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.102 |
During the follow-up period (1.1.1998 — 31.12.2019), 866 out of 9259 females with D3_COAGOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGOTHER | 2.037 [1.76, 2.36] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 960 out of 4790 males with D3_COAGOTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_COAGOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.198% | 0.418% |
| 5 | 1.027% | 2.321% |
| 10 | 2.67% | 5.891% |
| 15 | 4.974% | 10.495% |
| 20 | 8.859% | 18.28% |
Relationships between endpoints
↥Index endpoint: D3_COAGOTHER – Other coagulation defects
GWS hits: 27
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data